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Abstract
With the development of nanotechnology and nanomaterials, biosensors incorporated with
novel nanomaterials and nanostructures have shown significant potential in point-of-care
medical devices because of their rapid interaction with target analytes and their
miniaturized systems. Nanomaterials and nanostructures with special chemical, physical
and biological characteristics are able to enhance biosensors’ performance in terms of
sensitivity and selectivity. Therefore, my study focused on development of special
nanostructures used for advanced glucose biosensor. Monitoring of blood glucose level is
essential for diabetes management. However, current methods require people with diabetes
to have blood test with 5−8 times per day. Compared to other methods, optical and
magnetic techniques have a potential in developing minimally invasive or non-invasive,
and continuous glucose monitoring nanostructured biosensors. Consequently, this thesis
presented nanostructured optical and magnetic glucose biosensors by incorporating novel
nanomaterials and fabricating nanostructures for the next generation of glucose biosensor
in the tears. The glucose biorecognition biomolecule used in the biosensors was
Concanavalin A (Con A). Con A is a lectin protein that has strong affinity to glucose.
Fluorescence resonance energy transfer (FRET) technique was applied to develop optical
glucose biosensors. FRET biosensor is a distance-dependent biosensor. The fluorescence
emission of a donor molecule could be used to excite acceptor when the distance between
donor and acceptor is close enough (< 20 nm). Three different types of nanostructures were
developed and used as the donors of the glucose FRET biosensors. The first type of sensor
is a ZnO/quantum dots-based glucose biosensors. Hybrid ZnO nanorod array with
decoration of CdSe/ZnS quantum dots were prepared and coated on silicone hydrogel
which is a common materials of contact lens. The patterned nanostructured FRET sensor
could quickly measure rats’ tear glucose in an extremely small amount (2 µL) of diluted
tear sample. The second type of biosensor is based on upconversion nanomaterials.
Upconversion NaGdF4: Yb, Er nanoparticles with diameter of about 40±5 nm have been
prepared by polyol process and coated on silicone hydrogel to directly sense the tear
glucose level on the rats’ eye surface. The results show that the upconversion nanomaterials
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based lens sensor is able to quickly measure glucose in rats’ blood samples. The third type
of sensor utilizes the unique optical properties of carbon nanomaterial, fluorescent carbon
dots and graphene oxide nanosheets. The carbon dots with tunable fluorescence were
developed by a microwave-assisted process. The carbon dots are used as a fluorescence
donor in the biosensor, the chitosan coated graphene oxide acts as the fluorescence acceptor
to quench the emission of carbon quantum dots. In the presence of glucose, the emission
of carbon quantum dots could be restored as a function of the concentration of glucose.
Two linear relationships of the restored emission of the sensor and the concentration of
glucose were observed, in the range of 0.2 mM to 1 mM, and 1 mM to 10 mM, respectively.
On the other hand, a magnetoresistive (MR) nanostructured glucose biosensor has been
developed by exploiting hybrid graphene nanosheets decorated with FeCo magnetic
nanopartciles. The Fe3O4/silica core/shell nanoparticles are used as the magnetic label of
glucose, which could bind onto the surface of FeCo/graphene nanocomposited sensor. The
binding of magnetic label onto the hybrid graphene nanosheets can result in the change of
the magnetoresistance. The MR signal as a function of the glucose level of diluted rat blood
samples is measured in a range of 2 mM to 10 mM.
In summary, novel nanomaterials and nanostructures with special fluorescent and
magnetoresistive properties are fabricated for developing nanostructured glucose
biosensors, which could bring alternative approaches for convenient management diabetes.
Keywords
Diabetes, glucose sensing, nanostructured glucose biosensor, ZnO nanorod, quantum dots,
upconverting nanoparticles, silicone hydrogel, carbon dots, graphene oxide, FeCo
nanoparticles, graphene, fluorescence, magnetoresistance.
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Chapter 1
1 General Introduction and Motivation
1.1 Overview
1.1.1

Diabetes Mellitus

Diabetes mellitus is recognized as a chronic disease that is characterized by impaired
glucose metabolism which often contributes to long-term high blood levels of glucose
(hyperglycemia) and is reflected by blood glucose concentrations higher or lower than the
normal range of 80 mg/mL−120 mg/mL (4.4 mM−6.6 mM). [1-3]
According to the report of World Health Organization (WHO), over 400 million people in
2014 have to live with diabetes. The global prevalence of diabetes mellitus has caused
significant economic burden on health care system in the world. Blood glucose levels in
diabetes mellitus patients could fluctuate greatly throughout the day, causing serious
complications including heart attacks, strokes, high blood pressure, kidney failure,
blindness and limb amputation etc. [4-6] Therefore, the diagnosis and management of
diabetes mellitus require a tight monitoring of patients’ blood glucose level and the apply
corresponding treatments. The importance of sensing blood glucose is reflected on the fact
that glucose biosensors account for about 85% of the entire biosensor market. [7-8]
Nanotechnology is the term used to cover the design, construction and utilization of
functional structures with at least one characteristic dimension measured in nanometers.
[9] Such materials and systems could be designed to exhibit novel and significantly
improved physical, chemical and biological properties, phenomena and processes as a
result of the limited size of their constituent structures, particles or molecules. The reason
for such interesting and very useful behavior is that when characteristic structural features
are intermediate in extent between isolated atoms and bulk macroscopic materials; i.e., in
the range of about 109 m to 107 m (1 nm to 100 nm), the objects may display special
attributes substantially different from those displayed by either atoms or bulk materials.
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Ultimately this could lead to new technological opportunities as well as new challenges.
[10-12] The application of nanotechnology to glucose biosensor area are promising to
develop highly sensitive and selective nanostructured glucose biosensor. The
nanostructured glucose biosensors are promising to be minimally invasive or non-invasive
and be more compliant and smart for management and therapy of diabetes. Current
glucometers are designed to measure blood glucose levels of 3 mM to 25 mM. The sensing
target could be other body fluids other than blood. For example, tear or saliva, their glucose
concentration is much lower than blood glucose concentration. As the sensing analyte is in
low concentration, the sensing error would be a concern. Especially in the nanostructured
sensor, sensitivity and reproducibility are parameters that influence sensing results greatly.
Therefore, we need highly sensitive nanostructured glucose biosensor to have correct
results.

1.1.2

Nanostructured Glucose Biosensor

A biosensor is a device for the detection of an analyte that combines a biological sensing
component (enzyme, antibody, protein, DNA (deoxyribonucleic acid), RNA (ribonucleic
acid) etc.) with a physicochemical detector component, it consists of three parts: [13-17]
 The sensitive biological element, including biological material.
 The transducer in between.
 The detector element.
Biological
Recognition

Signal
Data processing
Transducer

Figure 1.1 Schematic of a biosensor.
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Nanomaterials and nanostructures have novel characteristics and special chemical,
physical and biological properties. The unique size-dependent tunable electronic, optical,
magnetic and mechanical properties of nanoscale materials (1−200 nm) offer excellent
platform for developing novel bioelectronics and biosensing devices. Nanostructured
biosensors are promising to enhance or supersede current analytical assays, and innovate
research and clinical practice. So far the unique optical nanomaterials suit themselves ideal
for

biosensing

application.

Fluorescent

exerting/interacting

nanomaterials

and

nanostructures are especially intriguing as they yield strong optical responses to incident
light and the response signal is linked with the target analyte, yielding extremely sensitive
detection. [18-23] In past years, most of the researches have been focusing on the
fluorescent quantum dots (QDs) and plasmonic gold nanoparticles (Au NPs). Recently,
new nanoscale materials have been developed including carbon-based nanostructures,
fluorescent polymer/silica nanoparticles, silicon dots, upconversion nanomaterials, alloyed
plasmonic nanoparticles, and gold and silver nanoclusters etc. [24-30]
Magnetic nanoparticles have special magnetic properties like superparamagnetic,
paramagnetic, ferrimagnetic and ferromagnetic etc. properties. These properties are
attributed to different compositions, crystal structures and temperatures etc. Especially the
superparamagnetic iron oxide (Fe3O4) have been widely used in biomedical applications
like thermal therapy, drug delivery etc. [31-32] Other magnetic nanomaterials are mostly
composed of magnetic elements of Fe, Co and Ni and applied in biomedical, catalysis and
energy areas. [33-34] Magnetic nanoscale materials are promising for developing
magnetoresistive biosensors.
Nanoscale materials normally need a surface covering as a barrier between the
nanomaterials and its ambient environment. This layer is usually composed of capping
molecules that bind directly to the surface and ideally prevents nanoparticles aggregating
or modifies nanostructures surface properties, so to disperse nanoparticles in water at a
various range of pH values or biological surrounding, and facilitate the contact between
modified nanostructures and external environment. The surface modification prevents
nonspecific adsorption of surrounding molecules onto the nanomaterials and
nanostructures surface, but also provides a conjugation place for functional biomolecules.
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Functional nanomaterials could hold manifold perspectives e.g. miniaturization, novel
materials properties and special functions, and complexity of technical device
developments. Nanomaterials conjugation with biomolecules could offer excellent signal
transduction of biological phenomena in the development of electronic, optical or magnetic
biosensors. Optical sensing is more advantageous in biosensor design because it has high
sensitivity, wide dynamic range, and multiplexing capabilities. [35-37] In contrast to
organic dyes and fluorescent proteins, nanoscale probes e.g. fluorescence resonance energy
transfer (FRET) nanomaterials and nanostructures provide enormous advantages in aspects
like signal brightness, photo-stability, and emission of multicolored light. [38-40]
Magnetic sensing uses magnetic nanoscale materials and nanostructures and is gaining
interest over recent years. One reason is that magnetic sensing in biological systems could
have almost zero noise due to the lack of magnetic elements in most biological components.
[41]

1.1.3

Fluorescence Resonance Energy Transfer

Fluorescence resonance energy transfer (FRET) is a nonradioactive process. In this
process, external excitation light excites the donor. The excited state fluorophore (donor)
could transfer energy to a nearby ground state fluorophore (acceptor), normally the distance
between donor and acceptor is 1 nm to 20 nm. FRET process is shown in the figure 1.2
below. The energy transfer efficiency is dependent on the distance between the donor and
acceptor, the closer they are, the higher efficient the FRET process is. [42-45]

Figure 1.2 Schematic of fluorescent resonance energy transfer (FRET) process, r is
the distance between the donor and acceptor.
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Fluorescent nanoscale materials and nanostructures are suitable as either donor or acceptor
for construction of FRET sensor. Some fluorescence quenching molecules or
nanomaterials are also used as fluorescence acceptor to quench the fluorescence. Quantum
dots, carbon dots, upconversion nanomaterials are usually used as either donor or acceptor.
[46-48] Noble plasmonic nanoparticles like gold or silver nanoparticles are often used as
fluorescence quencher, graphene oxide [49] are also used as fluorescence quenchers due to
their π electrons which could quench fluorescence. [50]

1.1.4

Upconversion Fluorescence

Upconversion is an optical anti-Stokes process. In the upconverting process, the
upconverting nanomaterials are excited by an excitation of near-infrared light (normally
980 nm) and then emits visible light of blue light, green light or yellow light. The emission
are adjustable by choosing different element dopants. [51-53] One advantage of using
upconversion nanostructured glucose biosensor is that near-infrared excitation are much
less harmful to human tissue than UV light. [54-58]
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3
2
hv2
hv1

hv3

hv2

2
1

hv1

1
a

b

Figure 1.3 Schematic principle of (a) conventional photoluminescence (Stokes)
process, and (b) upconversion photoluminescence (anti Stokes) process.
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Figure 1.3 presents the schematic of convention (Stokes shift) and upconverting (anti
Stokes shift) fluorescence process. The upconverting photoluminescence could be induced
by low-power and incoherent excitation sources, such as continuous-wave lasers, standard
xenon or halogen lamps, or even focused sunlight. [59] The primary theory of the
upconversion luminescence process (figure 1.3 (b)) is that a luminescent center at the
ground state 1 could absorb energy from either an excitation photon or a corresponding
energy transfer process to reach the excited state 2. Subsequently, another excitation
photon or a corresponding energy transfer process would promote the luminescent center
from excited state 2 to the excited state 3. Then, a radiative transition from this excited
state 3 back to the ground state or some other lower-energy state, results in a higher-energy
photon emission. In the upconversion luminescence process, the metastable intermediate
excited state is attained. This metastable intermediate excited state is expected to have a
relatively long lifetime so as to maintain a high population in the intermediate excited state
ahead of the second excitation energy. [60-62]

1.1.5

Magnetoresistance

Magnetic immunoassay is a novel immunoassay for early disease diagnosis compared to
traditional radioimmunoassay or fluoroimmunoassay. This assay utilizes magnetic
nanoparticle as biolabel and magnetoresistive sensor chip as detector. Most of the
biological components do not have magnetic background, therefore the magnetoresistive
sensor could have very high sensitivity. With careful design, MR sensor can even measure
the presence of single glucose molecules. As the ultra-high sensitivity of MR sensor, we
can use MR sensor to sense glucose in other body fluids like urine, saliva etc. For
electrochemical and optical sensing of urine, the urine is a complicated mixture and would
cause great errors for the detection. But MR sensor does not affected by the complicated
urine compositions. Magnetoresistance is an electron spin effect phenomenon. The
magnetoresistance effect was discovered early in the 1850s. At the early days, this effect
was smaller than 5%. Until the discovery of Giant Magnetoresistance (GMR) in the late
1980s, which has boosted the hard disk development in computer industry. The
magnetoresistance value is commonly calculated by the following equation: [63-66]
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MR% =

R(H) − R(0)
× 100%
R(0)

Where R(H) is the resistance under magnetic field H, R(0) is the resistance without external
magnetic field.
Normally a magnetic multilayer structure or magnetic multicomponent structure chip are
the format of a magnetoresistive chip. Under the external applied magnetic field, the
resistance of the MR chip is influenced, a magnetic nanoparticle label binding to the chip
surface would cause a minute magnetic field influence. This minute magnetic field could
be detected by the magnetoresistive sensor chip into resistance signal. [67-71] The
schematics of multilayer and multicomponent magnetoresistive chip is shown below.

Figure 1.4 Schematic of multilayer magnetoresistive system.
In the multilayer system, ferromagnetic layers and non-magnetic conductive layers are
sandwiched, the layer thickness is in the values of several or tens of nanometers. When the
two magnetic layers are magnetized parallel, the electrons antiparallel to magnetization
could travel through the magnetic layer smoothly. In condition without external applied
field, the magnetization direction in the system are antiparallel, either spin up electron or
spin down electron would scatter when passing the layers. As a result, this condition would
have a higher resistance. When the multilayer magnetization are paralleled by external field,
one spin direction of the electron could move smoothly through the layers, thus having a
smaller resistance. [72-77]
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In the multicomponent system, the magnetoresistance principle is similar. The more
scattering of electrons, the larger resistance it has. Some multicomponent systems are based
on graphene nanocomposites, doping magnetic nanoparticles like Fe3O4, FeNi3 [78-83]
onto graphene nanosheet could have magnetoresistive effects.

Figure 1.5 Schematic of multicomponent magnetoresistive system.

1.2 Current Challenges in Glucose Sensor for Diabetics
Currently, diabetes mellitus is a worldwide public health problem and the diagnosis and
management of diabetes mellitus requires a tight monitoring of blood glucose levels. [3]
Blood glucose levels in diabetics fluctuate significantly throughout the day, causing great
challenge of reliable and convenient glucose sensing. [7] The electrochemical glucometer
is the most widely used glucose sensor in daily use. However, the marketed glucometers
have certain level of invasiveness (blood required, often by finger prick to obtain a small
drop of blood) to patients. And the diabetics may need several times of finger pricks per
day. And this invasive sensing are often characterized by infection risks and discomfort to
diabetics.
Table 1.1 Summary of current glucose sensing methods.
Glucose
sensing

Impedance and
Electrochemical

Optical

methods

electromagnetic
spectroscopies
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Room for potential
boost

Advantage

Do not need patient

Most developed,

Non-invasiveness,

commercial product

blood samples,

externally

available

minimally or

accessible (skin,

noninvasive

saliva, tears), high
sensitivity
Invasive, finger prick

Disadvantage

several, times per day,

Less developed, not

infection risk,

much commercial

discomfort,

product

inconvenient

Poor accuracy,
temperature and
disease state impact
[84-86]

Table 1.1 summarizes the current glucose sensing profiles, electrochemical and optical are
the major two sensing mechanisms. Other noninvasive optical techniques include optical
coherence tomography, polarimetry, thermal infrared spectroscopy, photo acoustic
spectroscopy, and Raman spectroscopy etc. [87-90] However, these methods required big
machines in hospital and are not convenient for patients’ home care of measuring glucose.
The challenge in the glucose sensing lies in the development of minimally invasive or noninvasive glucose sensors with high selectivity and sensitivity. Optical sensing approach is
a sensitive and much minimally invasive path for glucose sensing. Magnetoresistive (MR)
sensing is a highly sensitive sensing technique. Because most of the biological components
are free of magnetic noise, therefore, MR sensing has very low or zero background noise
and very sensitive to target analyte with magnetic labelling. The highly sensitive MR
sensor could be designed to measure tear glucose or other body fluid glucose.
Other body fluids of skin sweat, urine, saliva, tears etc. have been studied and used as
glucose sensing target. Certain accuracy of sensing glucose has been attained. However,
each body fluid has its pros and cons. For example, sweat from different position may have
different components and causing measure errors. Urine is a colored mixture of various
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different compositions like protein, ions, impurities etc. and urine is varied from person to
person that have different diets. Saliva and tear are more adequate for accurate continuous
glucose sensing target. [91-94] Comparatively speaking, tear is more stable and continuous
than saliva. And tear glucose level has certain relationship to blood glucose. Other affecting
factors could be eye diseases which could affect the tear composition. This could be solved
by survey enough patients’ tear to get more understanding of tear glucose levels.
Table 1.2 shows the tear glucose level and blood glucose level for diabetics and healthy
person. Statistic results shows that blood glucose is approximately two times higher in
diabetics (circa 11 mM) compared with non-diabetes (circa 5 mM). Also, the average
concentrations of tear glucose for diabetes patients and non-diabetes are 0.35±0.04 mM
and 0.16±0.03 mM. [95-96] There is clearly enough evidence of a correlation between tear
glucose and blood glucose to justify continued efforts on developing tear glucose sensing
approach, although this correlation is not yet fully characterized. [95-97]
Table 1.2 Tear glucose level. [95-96]
Minimally invasive or non-invasive

Glucose level

optical/magnetic approaches

Diabetes

Non-diabetes

11 mM

5 mM

0.35±0.04

0.16±0.03

mM

mM

Tear
Better accessible, continuously

Blood

obtainable, stable, less susceptible
than urine, saliva, sweat etc.

Tear

However, the tear glucose level is very low, for diabetes patients and non-diabetes tear
glucose concentrations are 0.35±0.04 mM and 0.16±0.03 mM. And the other considering
factor is the acquisition of enough tear. Tear is not like urine, saliva or blood, average tear
flow rate is at about 1.2 µL/min with a range of 0.5 to 2.2 µL/min and the average normal
tear volume is about 6.2±2 µL. [98] Therefore, highly sensitive sensors are necessary for
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development of tear glucose sensors. Nanoscale materials and nanostructures are
promising to develop such highly sensitive and selective glucose sensors.
In order to measure the minute tear glucose concentration, sensitive sensor are required.
The tear glucose concentration is in the range of 0.1 mM to 0.5 mM. The tear amounts
needed are dependent on the sensitivity and design of the sensor. The marketed glucometer
could be designed to measure glucose concentrations in the range of 0.1 mM to 0.5 mM.
However, it required electrochemical reader, which would limit the glucometer
incorporated into contact lens. Another concern is that as the glucometer sensing range
decreases to 0.1 mM to 0.5 mM, the sensing errors are needed to be considered. For
example if the sample collecting sensing cell is designed to be 100 nm cubic which absorbs
sample by capillary effects or microfluidic control, the amounts of samples would be 0.001
µL. Therefore, highly sensitive sensors are necessary to construct such glucometer.
Magnetoresistive (MR) sensors are highly sensitive and able to measure up to several
glucose molecules. The development of MR glucose sensors are promising to sensing
glucose in tears and other body fluids.
The unique fluorescent, magnetonetoresistive nanomaterials and nanostructures have
special chemicophysical properties which make them ideal for biosensing with high
sensitivity and selectivity. [99-101] First of all, nanomaterials and nanostructures have
large surface area, which could greatly increase the sensor contact with target analyte. Thus
nanostructures sensor could sense very minute samples of tens of µL volume sample with
nanofabricated sensing cells in the nanoliter range. Secondly, nanoscale materials have
special size-dependent properties, novel chemical, physical and biological properties, these
properties enhance nanostructured sensor sensitivity as well. Moreover, the size-dependent
properties provide practical approach to control nanomaterials and nanostructures
properties. Various chemical methods, physical methods, top-down, bottom-up approaches
have been developed to synthesize and fabricate different nanoscale materials and
nanostructures with controlled surface fluorescent and magnetoresistive properties.
The fluorescent based nanostructures are promising for developing contact lens based tear
glucose sensor. This contact lens based glucose sensor is a minimally invasive or non-
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invasive approach. On the other hand, the magnetoresistive method provide high sensitivity
sensing technique. Although the MR sensor is currently quite difficult to be incorporated
into contact lens sensor to sense tear glucose, it is worthy to develop MR glucose sensor to
sense blood glucose, urine glucose, sweat glucose, saliva glucose or other body fluids
glucose. These body fluids are clear of magnetic interference and MR glucose sensor could
provide highly sensitive results.

Figure 1.6 Schematic of current challenge of marketed electrochemical glucometer
and possible solving method by development of fluorescent, magnetoresistive
nanostructured glucose biosensor.
In summary (figure 1.6), the design and fabrication of fluorescent, magnetoresistive
nanostructured glucose biosensors are promising to solve the current electrochemical
glucometer problem of invasiveness, finger pricks, possible infections etc. while providing
diabetics with much compliant glucose sensing alternatives and better management of
diabetes diseases.

1.2.1

Objectives and Outcomes

The major motivation of my work is that the development of minimally invasive or noninvasive sensitive and selective glucose measurement method is urgent for diabetes
patients. Optical approaches are less developed and have potential development. The
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optical approaches meet the requirement of minimal invasiveness or non-invasiveness,
highly sensitivity and highly selectivity. Magnetoresistive technique also has high
sensitivity and selectivity due to lack of magnetic interference in most biological
components. Therefore, fluorescent, magnetoresistive nanostructured glucose biosensor
are promising in replacing current marketed electrochemical glucometer.

Figure 1.7 Schematic of my work on four nanostructured glucose biosensors.
The overall outcome of my work (figure 1.7) is to utilize various nanoscale materials and
fabricated nanostructures to construct nanostructured glucose biosensors for tear glucose
sensing and blood glucose sensing. The fluorescent and magnetoresistive approaches are
studied. Several goals are set up to fulfill the objective as stated below.
[1]

To synthesize a variety of fluorescent, magnetic nanomaterials and fabrication of
nanostructures.

[2]

To develop efficient methods for surface functionalization and bioconjugation of
nanomaterials’ and nanostructures’ surface.

[3]

To fabricate nanostructured glucose biosensors using the synthesized fluorescent,
magnetic nanomaterials.
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[4]

To explore the nanostructured glucose biosensors (based on the synthesized
fluorescent, magnetic nanomaterials) for tear glucose sensing, blood glucose
sensing applications.

To achieve these goals, the following specific objectives are sought in various chapters of
the thesis.
 Chapter 1 General Introduction and Motivation
This chapter provides an overview of diabetes mellitus, biosensors, nanostructured
glucose biosensors, sensing techniques/mechanisms, current challenge in glucose
sensing area and the outline of objectives and layout of the thesis.
 Chapter 2 Background and Literature Review
This chapter presents a general review of fluorescent exerting/interacting nanoscale
materials (quantum dots, upconversion nanoparticles, nanocarbon materials of
carbon dots, graphene oxide and graphene) and magnetoresistive nanomaterials for
nanostructured glucose biosensors.
 Chapter 3 Development of ZnO/QD Patterned Nanostructured Glucose Biosensor
The objective of this chapter was to develop a fluorescence resonance energy
transfer nanostructured glucose biosensor. This chapter presents the preparation of
patterned ZnO nanorod array decorated with CdSe/ZnS quantum dots on hydrogel
film. The surface of the patterned nanostructured was modified with Con A protein
and binding with malachite green dextran. This nanostructured glucose biosensor
was used to measure rats tear glucose.
 Chapter 4 Development of Upconversion NaGdF4: Yb, Er Glucose Biosensor
The objective of this chapter was to develop upconversion NaGdF4: Yb, Er
nanomaterials based fluorescence resonance energy transfer nanostructured
glucose biosensor. This chapter presents the preparation of upconversion NaGdF4:
Yb, Er nanomaterials by a polyol process. The surface of the upconversion
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nanomaterials was as-synthesized modified by amine groups ( − NH2). The
nanoparticles was further surface modified with Con A and deposited onto hydrogel
film surface to construct nanostructured glucose biosensor to measure rats’ blood
glucose.
 Chapter 5 Development of Carbon Dots/Graphene Oxide Glucose Biosensor
The objective of this chapter was to develop nanocarbon materials based
fluorescence resonance energy transfer glucose nanobiosensor using carbon
dots/graphene oxide. This chapter presents the preparation of fluorescent carbon
dots by a microwave assisted process. Graphene oxide was prepared by a
Hummers’ method. Carbon dots work as fluorescence donor with surface modified
with Con A, graphene oxide work as fluorescent acceptor (fluorescent quencher).
This glucose nanobiosensor was explored to measure rats’ blood glucose.
 Chapter 6 Development of FeCo/graphene Magnetoresistive Nanostructured
Glucose Biosensor
The objective of this chapter was to develop FeCo/graphene magnetoresistive
nanostructured glucose biosensor. This chapter presents the preparation of FeCo
magnetic nanoparticle, graphene nanomaterials and FeCo/graphene nanocomposite
by a polyol process. Fe3O4/silica core/shell nanoparticles were prepared and used
as magnetic label. The FeCo/graphene nanocomposite film surface was modified
with Con A, the magnetic label surface was modified with phenylboronic acid (can
bind to glucose molecule). The magnetoresistive nanostructured glucose biosensor
was used to measure diluted rats’ blood glucose.
 Chapter 7 Summary and Recommendations
This chapter provides a general conclusion of the above studies and
recommendations for future work on the nanostructured glucose biosensors.
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Chapter 2
2 Background and Literature Review
2.1 Nanomaterials for Glucose Biosensing
Historically, the glucose was analyzed by colorimetric reaction methods. The most widely
used method is Miller’s colorimetric method. [1] Because glucose solution has no
absorbance, no fluorescence in visible range, most of the analysis method in early days was
dependent on the glucose chromogenic reaction. Take Miller method as demonstration, the
glucose carbonyl group (C=O) is oxidized and at the same time, 3, 5-dinitrosalicylic acid
(DNS) is reduced to 3-amino, 5-nitrosalicylic acid under alkaline conditions with colored
products. The glucose content is related to the colorimetric products which could be
quantified by UV-vis spectroscopy.
Sensing glucose is very important in food industry, pharmaceutical industry and specially,
glucose monitoring is critical for diabetes management. Diabetes symptom is characterized
with long term hyperglycemia and the monitoring of patients glucose state is required for
the disease therapy. Although the electrochemical method for sensing glucose is marketed
and widely used among diabetes patients, the multiple times of finger pricks daily to get
minute blood for glucose sensing may cause patients with weak immune systems with
infections and uncomfortable feelings. Therefore, more patient friendly, minimally
invasive or non-invasive fluorescent detection methods has gained focus recently. [2-5]
Fluorescent sensing has the following advantages: [6-9] (a) extremely sensitive, (b)
minimally invasive or non-invasive, (c) fluorescence intensity and fluorescence lifetime
could be utilized, (d) could provide structure and micro-environment of molecules, (e)
fluorescence resonance energy transfer (FRET) technique could be utilized. Another
promising glucose sensing approach is magnetoresistive method which has high sensitivity
due to absence of magnetic interference in most biological components.
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Nanotechnology has brought profound influence in biosensors area, the most favorable
advantage of nanostructured sensor is their high sensitivity and selectivity and the
miniaturization of sensor device. The development of nanotechnology allows materials to
be prepared and fabricated in reduced dimensions at the nanoscale, forming construction
of nanoscale structures for high throughput assay with the integration of microfluidics
devices, and strengthening the biological activity of the biological components by using
novel nanoscale materials and nanostructures. Nanomaterials and nanostructures have
special chemical, physical and biological properties compared to their bulk counterpart.
[10-14] The fluorescent, magnetoresistive nanomaterials and nanostructures have distinct
novel properties and provide extensive nanoplatform for developing new nanostructured
biosensors for glucose sensing. [15-20] Biosensors are sensors composed of or involved
with a biological component. [21-24] Because the biological components have high
sensitivity and selectivity to specific molecules, thus the utilization of biological
component create highly accurate sensing devices for a variety of molecules including
glucose, urea, cholesterol etc.
Biosensors are widely applied in the areas of food industry, pharmaceutical industry,
environment monitoring and medical diagnostics etc. The early biosensors were using
biocomponents decorating on the electrode surface as target recognizing parts. As the
nanotechnology flourished, the conjugation of biocomponents onto nanomaterials and
nanostructures has formed nanostructured biosensors with prevalent applications. The
conjugation may need further control to offer reproducibility. As the equivalent size of
nanoscale materials and nanostructures to biological systems, the nanostructured
biosensors are promising tools for sensing biological activity in vivo and in vitro. [25-28]
Some common biological receptors have been used in detection of glucose in fluorescent
nanostructured biosensors, like Concanavalin A (Con A), glucose oxidase, glucose
dehydrogenase and hexokinase/glucokinase, glucose binding proteins etc.

2.2 Detection Principles of Nanostructured Fluorescent
Biosensor
Fluorescent nanomaterials and nanostructures are suitable signal transducers for
correlating the glucose signals into fluorescent signals, either in peak intensity, peak shift,
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or fluorescent lifetime etc. Fluorescence resonance energy transfer (FRET) is
acknowledged as a sensitive and reliable analytical technique and has been widely
employed in the fluorescence biosensing systems. Fluorescent nanomaterials and
nanostructures could work as a good platform for the bioconjugation of glucose recognized
biomolecules. The bioconjugation methods include chemical bioconjugattion or physical
adsorption onto the nanomaterials and nanostructures. The biomolecules are greatly
stabilized when bioconjugated or adsorbed onto the nanomaterials and nanostructures with
higher biological activity and stability.
The primary sensing mechanisms include glucose direct binding, glucose competitive
binding and fluorescent dye release etc., which would introduce corresponding
fluorescence intensity changes, fluorescence turn-on or turn-off, fluorescent lifetime
changes etc. Another type of sensing mechanisms employs the glucose catalysis oxidation
reaction. The reaction products often contain hydrogen peroxide (H2O2) and/or gluconic
acid (causing pH change). The oxidizing and acidic products then influence the
fluorescence signal. Some of the glucose catalysis reactions are shown in the following
equation 1−4.
Glucose + Concanavalin A ⇋ Concanavalin A∗

Glucose + Glucose binding protein ⇋ Glucose binding protein∗

Equation 1

Equation 2

In equation 1 and 2, the glucose binding reaction is dynamic and reversible, the * mark
represent the biomolecules binding with glucose. The fluorescence change could be
induced by, (a) binding protein is labeled with fluorescent dye or fluorescent protein. The
binding state would change the fluorescence of the fluorescent label. (b) binding protein is
originally binding with other saccharide molecules, glucose competitively bind to the
protein and replace the other saccharide molecules. The saccharide molecules could have
optical properties, e.g. fluorescence, absorbance, etc. Therefore, the change of the optical
signal could be correlated with glucose concentration; and the optimal parameters for
improving sensor’s performance include the types of the glucose binding proteins, and the
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ratio of the glucose and glucose binging proteins. The Concanavalin A binds glucose and
does not produce products.
Glucose oxidase

Glucose + Oxygen →

Gluconic acid + Hydrogen peroxide

Glucose dehydrogenase

Glucose + Oxygen →

Gluconic acid

Equation 3

Equation 4

+ Hydrogen peroxide
Equation 3 and 4 represent the glucose catalysis reactions. The products contain gluconic
acid and/or hydrogen peroxide. Provided the fluorescence of nanomaterials and
nanostructures would be affected by the hydrogen peroxide and pH change. Thus the
glucose content could be analyzed by correlating with the fluorescence change.

2.3 Glucose Recognition Biomolecules
Various glucose recognized biomolecules have been investigated and they include direct
glucose binding by Concanavalin A, glucose binding proteins etc. Glucose catalytic
oxidization reaction employ certain oxidase like glucose oxidase, glucokinase, hexokinase
and glucose dehydrogenase. Concanavalin A (Con A) is a plant lectin protein extracted
from Jack beans. Con A tetramer molecule has four binding sites for glucose molecules
and has been widely used in glucose sensing assays.
Another type of glucose sensing biomolecules is the glucose binding proteins (GBP), which
is one of the binding proteins found bacteria like Escherichia coli. These glucose binding
proteins have extremely high selectivity and sensitivity for glucose, of which the binding
constants of the proteins to glucose are in the micromolar (µM) range. The sensitivity and
selectivity of glucose binding proteins render them ideal for GBP based glucose biosensor
development for sensing tear glucose and other non-blood body fluids glucose. [29] The
sensitivity and selectivity of GBP could be engineered by recombinant protein technique.
[30-31]
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2.4 Fluorescent Exerting/Interacting Nanomaterials
The mostly researched fluorescent exerting nanomaterials include fluorescent
semiconductor quantum dots (QDs), dye-doped silica nanoparticles (DDSNs), lanthanide
doped nanomaterials and upconversion nanoparticles (UCNPs), fluorescent gold/silver
metal nanoclusters etc. [32-35] Some other nanomaterials are fluorescent interacting
quenchers and have been investigated in the fluorescent assays as well. Plasmonic
gold/silver nanoparticles are employed as fluorescent quenchers. [36]
Another big family of nanomaterials is the carbon nanomaterials, some carbon based
nanomaterials are fluorescent and others are fluorescent quenchers. Graphene/graphene
oxide, carbon dots, carbon nanotubes etc. carbon nanomaterials have been heavily studied
in the fluorescent glucose biosensing. [37-39] Graphene/graphene oxide nanomaterials are
fluorescent quenchers due to their large π electron plane on the nanosheet plane, which
could quench fluorescence through fluorescence resonance energy transfer (FRET). On the
contrary, carbon dots and carbon nanotubes are promising strong fluorescent nanomaterials
for biosensing applications. Carbon dots could be prepared by many facile methods and
the scale up production of carbon dots is not difficult. Carbon nanotubes emit fluorescence
in the near-infrared range. This characteristic make carbon nanotubes very favorable for
biomedical applications. However, currently the carbon nanotubes have not yet been able
to be prepared facilely. [40]
Some other fluorescent nanomaterials include metal oxide nanostructured nanomaterials.
As metal oxide nanostructures provide large effective surface areas for biomolecules
immobilization, which could maintain better conformation, desired orientation and high
biological activity of immobilized biomolecules. Thus a superior sensing characteristics
was achieved. ZnO nanostructure film is a typical weak fluorescent nanomaterials, which
is often used as substrate for nanobiosensing. For other metal oxide nanostructures, they
are often used in electrochemical biosensing due to their good electrical properties. But
still, these metal oxide nanostructures are potential candidates as device for fluorescent
glucose biosensing, and they could be further incorporated into other devices. [41-44]
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Figure 2.1 General steps involved in the application of functional nanomaterials.
Reprinted with permission from [45], Copyright (2010) American Chemical Society.
(Permission in Appendix 1)

Figure 2.2 Examples of nanomaterials and their functional groups for biological
applications. Reproduced from [46] with permission of the Royal Society of
Chemistry. (Permission in Appendix 2)
The nanomaterials and nanostructures normally need surface functionalization to obtain
desirable physiochemical properties for various applications. As shown in figure 2.1, from
the synthesis of a nanoparticle, then surface coating is applied to form core-shell
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nanoparticle. Continuously, ligand exchange and functional groups are grafted or
bioconjugated on the outer surface. The modification and functionalization of
nanomaterials and nanostructures could make them more water soluble and biocompatible
for further application in biosensing systems.
Nanomaterials and nanostructures surface functionalization aims to utilize them in
catalysis, adsorption, drug delivery carrier, bioimaging, nanobiosensor and nanomedicine
etc. applications. The surface properties have great influence on the nano-bio interface.
Hydrophilic and hydrophobic surfaces can affect the interaction of nanomaterials with
biomolecules and proteins adsorption. Related nanomaterials and nanostructures surface
modification reviews [46-51] have demonstrated various chemical, physical modifications
and bioconjugation methods. Various functional groups and applications of nanomaterials
and nanostructures could be visualized with suitable surface modification and fabrications
as shown in figure 2.2.

2.4.1

Semiconductor Quantum Dots

Quantum dots are tiny semiconductor nanoparticles with diameters in the range of 2−10
nm, containing roughly 200 − 10,000 atoms and characterized by size-dependent
fluorescent property, broad excitation range, narrow emission peak, large Stokes shift,
ultrahigh brightness, high quantum yield and photo-stability. The synthesis method of the
quantum dots are mature and abundant. The organic phase synthesis could yield high
quality quantum dots, which are oil phase soluble, thus further surface modification is
necessary to render their usage in biological sensing. [52-54] However due to the
semiconductor elements’ cytotoxicity (Cd element), the bio-application of quantum dots
are hindered greatly. Normally a coating layer like silica shell, polymer shell or carbon
shell would be coated on the surface of the semiconductor quantum dots to improve their
water solubility and biocompatibility. [55-58] Compared to traditional fluorescent dye,
Green Fluorescent Proteins (GFP) or enhanced GFP, quantum dots has superior
luminescent properties like photo-stability to ambient environment, high quantum yield
and bright size-dependent excitation photoluminescence. These luminescent properties of
the semiconductor nanocrystals favor them as nanobiosensing probes. [59-60]
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Figure 2.3 Chemical structure of the QDs-Con A-β-CDs-Au NPs nanobiosensor and
schematic illustration of its FRET-based operating principles. Reproduced from [61]
with permission of the John Wiley and Sons. (Permission in Appendix 3)
An assembled competitive fluorescent glucose nanobiosensor was constructed (figure 2.3).
[61] The designed nanobiosensor composed of modified quantum dots and plasmonic gold
nanoparticles. As schematic shows in figure 2.3, the sensing mechanism is through the
Fluorescence Resonance Energy Transfer (FRET) between quantum dots (energy donor)
and gold nanoparticles (energy quenching acceptor). Concanavalin A were modified onto
the quantum dots surface and β-SH-cyclodextrin were modified on the gold nanoparticle
surface. Before glucose was introduced, the quantum dots and gold nanoparticles were
connected by the Concanavalin A binding of the β-SH-cyclodextrin, and the fluorescence
of the quantum dots was quenched by the plasmonic gold nanoparticles. After the glucose
was introduced, the glucose competed for the binding to the Concanavalin A, then the
plasmonic gold nanoparticles were separated from the quantum dots. As a result, the
emission of quantum dots was recovered. Experimental results illustrated that the increase
in fluorescence intensity was proportional to glucose concentration in the range of 0.1−50
µM when optimized experimental conditions were reached. Also the serum test results
showed that this fluorescent glucose nanobiosensor has excellent glucose selectivity over
other sugars and most biological interferents.
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Figure 2.4 The glucose dehydrogenase biocatalyzed generation of NADH by the
oxidation of glucose enables the fluorescence detection of glucose by methylene-bluefunctionalized CdSe/ZnS quantum dots. Reproduced from [62] with permission of the
John Wiley and Sons. (Permission in Appendix 4)
Another quantum dots based glucose nanobiosensor was developed utilizing glucose
catalytic reaction (figure 2.4). [62] Glucose dehydrogenase modified CdSe/ZnS quantum
dots were prepared to sense glucose. The sensing technique is fluorescence resonance
energy transfer (FRET). The nanobiosensing mechanism is demonstrated in figure 2.4.
Before adding glucose, the fluorescence of the quantum dots was quenched by the
methylene blue. After adding glucose, the biocatalytic reactions took place and the
fluorescence of quantum dots was recovered. In the biocatalytic reaction, glucose was
converted to gluconic acid, the glucose dehydrogenase biocatalytic reaction was mediated
by the NADH−NAD+ (reduced-oxidized form of NAD)pair (NAD=Nicotinamide adenine
dinucleotide), methylene blue was reduced by NADH to colorless MBH, then the
fluorescence resonance energy transfer between quantum dots and methylene blue was
terminated. The detection limit of this fluorescent glucose nanobiosensor was as low as 105

M.

A fluorescent nanostructured glucose biosensor chip utilizing glucose oxidase was
developed by Tang et al. (figure 2.5), [63] in which a layer-by-layer assembly technique
was used to fabricate the thin film sensor. The facile step by step process is shown in figure
2.5, firstly polymer poly(allylamine hydrochloride) (PAH) and CdTe quantum dots were
assembled on a substrate. Then three bilayers of polymer film of poly(allylamine
33

hydrochloride) (PAH) and polystyrenesulfonate (PSS) were assembled on top to avoid
possible interference. Next, glucose oxidase (GOD or GOx) and PAH were deposited. The
layer-by-layer thin film structure of (PAH/CdTe)x(PAH/PSS)3(PAH/GOD)y was
constructed. The fluorescence of CdTe quantum dots was quenched by the H2O2 produced
by the glucose catalytic oxidization reaction. This glucose sensor has the advantage of
adjustment of the quantum dots layer composition and the glucose oxidase layer
compositions for adaptation to different sensing environment. Experimental results showed
that the glucose responsive range for (PAH/CdTe)12(PAH/PSS)3(PAH/GOD)3 was 0.5
mM−16 mM.

Figure 2.5 Sensing assembly: (a) top 3 bilayers of PAH/GOD, (b) 3 bilayers of
PAH/PSS, and (c) 12 bilayers of PAH/CdTe QDs. PAH=poly(allylamine
hydrochloride), GOD=glucose oxidase, PSS=polystyrenesulfonate, QD=quantum
dots. Reprinted with permission from [63], Copyright (2009) American Chemical
Society. (Permission in Appendix 5)

2.4.2

Fluorescent Polymer/Silica Nanomaterials

Another fluorescent nanomaterials are dye-doped silica nanoparticles or polymer
nanoparticles. As polymers nanoparticles could employ many different monomers and thus
they are varied from each other, but the idea is more or less the same with dye-doped silica
nanoparticles by incorporating fluorescent elements inside polymerized matrix. Silica is a
highly biocompatible material and the dye could be covalently conjugated or by physical
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doping into the silica matrix. Due to the silica protection of doped dye, the photo-stability
of doped dye is greatly improved. Moreover, the silica matrix provides a very good surface
platform for surface functionalization and construction of various silica structures,
including solid silica nanoparticles, mesoporous silica nanoparticles, hollow silica
nanoparticles, core-shell silica nanoparticles and Janus silica nanoparticles etc. [64-65]
The universal silane chemistry could be well adapted to functionalize the silica matrix with
various functional groups like amine group (−NH2), carboxylic group (−COOH), thiol
group (−SH) and epoxy group (−CHOCH2) etc. The most common silane monomer is
Tetraethyl Orthosilicate (TEOS), and the most used synthesis process is sol-gel process.
The mesoporous silica nanomaterials have a large specific surface area and the mesopores
are good container for loading fluorescent reporters. The mesopores could be gated by
some target molecule. Silica or polymer nanoparticles represent useful tools for glucose
sensing.

Figure 2.6 Schematic illustration of the process for protein encapsulation in silica
nanoparticles. After formation of a microemulsion, silica nanoparticles are formed
by addition of ammonium hydroxide to increase the pH. In a last step, the inverse
microemulsion is redispersed in water to give an aqueous silica dispersion with the
FRET-based biosensor encapsulated in the silica nanomatrix. A specific interaction
between the silica matrix and the biosensor is mediated by a silica–calcium–hexa-
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histidine-tag complex. Reproduced from [66] with permission of the Royal Society of
Chemistry. (Permission in Appendix 6)
A fluorescence resonance energy transfer (FRET)-based glucose biosensor stabilized by
incorporating into silica nanoparticle were prepared (figure 2.6). [66] The incorporation
process is shown in figure 2.6, a microemulsion fabrication method is adopted in the
synthesis. Silica matrix greatly stabilized the FRET biosensor from thermal and chemical
denaturation. The specific interaction between hex-histidine-tag of the biosensor protein
and a calcium silica complex was achieved, and the affinity to glucose was preserved. This
study revealed that silica matrix has the stabilization effect of biomolecules compared to
bare FRET-biosensor. This silica coated fluorescent glucose nanobiosensor was very
promising for in vitro and in vivo sensing glucose.

Figure 2.7 Ru(bipy)32+ loaded mesoporous silica capped with cyclodextrin-modified
glucose oxidase (CD-GOx) for the detection of glucose. Reproduced from [35] with
permission of the Royal Society of Chemistry. (Permission in Appendix 7)
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A gated mesoporous silica nanobiosensor for glucose sensing was prepared (figure 2.7).
[35] This nanobiosensor was shown in figure 2.7, the fluorescent reporter (ruthenium
bipyridine complexes) was loaded into the silica mesopores. The mesopores outlets were
grafted with propylbenzimidazole moieties. Then the cyclodextrins modified glucose
oxidase (CD-GOx) bioconjugates interacted with propylbenzimidazole groups by forming
the inclusion complex, which blocked the loaded fluorescent reporters. After glucose was
introduced, gluconic acid was produced and causing the protonation of benzimidazole
group. Then the CD-GOx bioconjugates were detached from the silica nanoparticles,
triggering the release of fluorescent ruthenium bipyridine complexes. A linear glucose
responsive range of 0.1 mM to 10 mM was achieved by this nanobiosensor assays. Blood
glucose levels of healthy and diabetics are 3 mM−8 mM and 9 mM−40 mM respectively.
This gated mesoporous silica nanobiosensor were promising for the design of fluorescent
nanobiosensor for glucose detection.

2.4.3

Upconverting Nanomaterials

Upconversion nanoparticles (UCNPs) is a large family of fluorescent nanomaterials.
Upconverting nanomaterials have superior luminescent properties like long luminescent
lifetime, large anti-Stokes shift, narrow emission bands and high photo-stability compared
to quantum dots. Moreover upconverting nanomaterials could be modified with proper
surface coatings and functional groups, thus having high biocompatibility and low toxicity
that would favor them as a new generation of fluorescent nanoprobes for biomedical
applications. [67-71] Normally, near-infrared 980 nm excitation is used to excite the
upconverting nanomaterials to emit green, yellow or red light in the visible range (400−700
nm). The emission peaks are sharp and tunable by adjusting the doping lanthanide elements
and corresponding ratios. Commonly used doping elements include Er, Tm, To etc., of
which Er dopant enhances the green emission, Ho dopant enhances the yellow light while
the Tm dopant enhances the red light, respectively. [72-74]
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Figure 2.8 (a) Schematic diagram for the selective detection of H2O2 and glucose and
the specific recognition of H2O2 by HRP and TMB. (b) The colorless TMB was
oxidized into blue oxTMB by polymerization. (For interpretation of the references to
color in this scheme legend, the reader is referred to the web version of this article.)
Reprinted from [75], Copyright (2015), with permission from Elsevier. (Permission
in Appendix 8)
An upconverting nanomaterials based fluorescent glucose nanobiosensor was studied as
shown in figure 2.8. [75] In the sensing assay, glucose was first incubated with glucose
oxidase at 37 oC. This reaction produced hydrogen peroxide. The produced H2O2 mixed
with green emitting NaYF4: Yb3+/Er3+ upconverting nanoparticles and colorless 3, 3’, 5,
5’-tetramethylbenzidine (TMB) and horseradish peroxidase (HRP). The mixture was
further incubated at room temperature for 10 minutes before measuring the fluorescence.
The sensing mechanism was that the H2O2 oxidized colorless TMB into blue oxidized TMB
(oxTMB) by assistance of HRP. As a result, the upconverting green emission was quenched
by the oxidized TMB. Their results showed that the glucose sensing linear range was 100
nM−4 µM and the analysis results of serum glucose samples were in good accordance with
hospital detecting results.
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Figure 2.9 Design and principle for H2O2 and glucose detection using a MnO2nanosheet-modified UCNP nanocomposite. Reprinted with permission from [76],
Copyright (2015) American Chemical Society. (Permission in Appendix 9)
Another upconversion fluorescence turn-on nanosystem was developed (figure 2.9). [76]
Manganese dioxide (MnO2) nanosheets were modified on upconverting nanoparticle
surface and quenched the upconversion. Glucose oxidase catalyzed glucose and produced
gluconic acid and H2O2. The H2O2 reduced the MnO2 nanosheets to Mn2+. Consequently
the upconverting fluorescence was then turned on. By correlating the upconverting
fluorescence at 450 nm, glucose concentrations range of 0 µM−400 µM could be detected.

2.4.4

Gold/Silver Nanoparticles/Nanoclusters

Noble metal nanoparticles show distinct Surface Plasmon Resonance (SPR) phenomenon
and noble metal nanoparticles are often utilized as fluorescence quenchers. Typical noble
metal nanoparticles include gold nanoparticle, silver nanoparticle, platinum nanoparticles
etc. These plasmonic nanoparticles are widely used in biosensing applications.
Interestingly, as the size of the noble metal nanoparticles decrease to the extent of several
to tens of atoms, roughly smaller than 1 nm. These noble metal nanoclusters would exhibit
fluorescence properties and the fluorescence is tunable by controlling the nanoclusters size
or atom numbers. [77-80]
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Plasmonic gold metal nanoparticles are inert and stable in biological systems, representing
a high biocompatibility. Also the gold atoms on the surface are especially prone to attach
with thiol groups ( − SH), which facilitate the surface functionalization of gold
nanoparticles. These properties make gold nanoparticles as a very useful as fluorescent
quenching nanobiomaterials for biosensig. [81-82] In the synthesis of most metal quantum
clusters, proteins are always used to assist formation and stabilization of the nanoclusters.
Nanoclusters are size-equivalent to biological systems, have high biocompatibility and
strong fluorescence. The size of noble nanoclusters are less than 1 nm. The compositions
are gold or silver which is inert to biocomponents. The strong fluorescence comes from the
discrete band gap due to their smaller size compared to gold/silver nanoparticles (2-50 nm).
They have been widely investigated and applied in biosensing area. [83-84]

Figure 2.10 Schematic sensing mechanism of the sensor for urea and Glucose
detection. Reproduced from [85] with permission of the Nature Publishing Group.
(Permission in Appendix 10)
Fluorescent silver nanoclusters conjugate was developed as a nanobiosensor for glucose
sensing (figure 2.10). [85] Silver nanoclusters were synthesized and its sensitivity to pH
was used for sensing glucose as indicated in figure 2.10. The pH sensitivity originated from
the carboxylic groups (−COOH) on the silver nanoclusters surface. These carboxylic
groups could create an easily formed molecular interaction (e.g. hydrogen bond) among
silver nanoclusters. And the interaction is pH-switchable. This interaction consequently
affected the fluorescence of silver quantum clusters. Therefore, the gluconic acid produced
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by the glucose biocatalytic reaction could influence the fluorescence of the silver
nanoclusters. The measured results indicated the glucose sensing range was 0.3 mM−13
mM and the silver quantum clusters could be regenerated by recovering the pH (urea
sensing, urea catalyzed by urease to increase the pH).

2.4.5

Fluorescent Carbon Nanomaterials

Fluorescent carbon nanomaterials are a broad family of carbon nanotube, graphene oxide,
graphene quantum dots and carbon dots. Although the fluorescent mechanisms of some
carbon nanomaterials are not yet fully understood, they have already been widely
researched and applied in biosensing. [86-91] The main reason for their intense study is
due to the benign nature of nanocarbon materials in biological systems and their special
fluorescent characteristics. With proper surface coating of nanocarbon materials, their
cytotoxicity are greatly lowered and benign to biological systems. Among these fluorescent
carbon nanomaterials, graphene oxide also has weak fluorescence, graphene quantum dots
and carbon dots, carbon nanotubes have good fluorescence. Multicolor graphene quantum
dots and carbon dots have been widely studied. Graphene quantum dots (1−10 nm)
sometimes are categorized into minimized sized graphene oxide (several hundred µm). The
graphene quantum dots are also categorized as one kind of single sheet carbon dots. Here,
we would take carbon dots as a representative for fluorescent carbon nanomaterials and
discuss their fluorescent properties. The most distinguished fluorescent characteristics of
carbon dots is their excitation-dependent emission. For the majority carbon dots
investigated so far, they possess this special character. As the excitation moves across from
UV to even near-infrared, the carbon dots emission moves in correspondence with the
excitation wavelength. [92-99] Some carbon dots have stabilized emission position even
by shifting excitation wavelength, some carbon dots even possess upconversion
fluorescence when excited by near-infrared light. [100-102]
Compared to other glucose recognized biomolecules, the glucose binding proteins are nonenzymatic glucose bioreceptors. And GBP could bind glucose with high sensitivity and
selectivity. The binding event could naturally occur and no by-products are produced. After
the GBP is binding with glucose. The conformation of binding proteins would change
accompanied with hinge bending. This hinge bending behavior could be used to transduce
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the binding event into fluorescent signal by using nanomaterials and nanostructures.
Efficient glucose biosensing could be realized by using this kind of glucose binding
protein. Taking advantage of recombinant protein engineering techniques, various glucose
binding proteins could be design and produced as versatile nanobiotools for glucose
sensing.

Figure 2.11 Glucose-binding protein (GBP) covalently conjugated to a fluorescent
single-walled carbon nanotube (SWNT) is shown to act as an optical switch. Hingebending response to glucose causes a reversible exciton quenching of the SWNT
fluorescence with high selectivity. Reproduced from [103] with permission of the John
Wiley and Sons. (Permission in Appendix 11)
A glucose binding protein-single carbon wall nanotube nanobiosensor was developed
(figure 2.11). [103] The mechanism of this nanoscale glucose sensing device was shown
in figure 2.11. First the carbon nanotube was wrapped and stabilized by carboxylated
poly(vinyl alcohol) (cPVA). Then the glucose binding protein (GBP) was covalently
bioconjugated with the cPVA. The emission of the single walled carbon nanotube was in
the near-infrared area, which is the biological transparent windows. The adding of glucose
led to the GBP hinge bending and conformation change. This allosterically change
influenced the near-infrared fluorescence of carbon nanotube. Experimental data showed
that the glucose sensing range was 2.5 mM−50 mM and the fluorescence change was
reversible due to the reversible GBP binding behavior.
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An important advantage of carbon dots over other fluorescent nanomaterials is their high
water solubility and high biocompatibility after proper surface modification, which renders
them very suitable for biomedical applications. Moreover, the surface of carbon dots often
consist of carboxylic groups (−COOH), amine groups (−NH2) and other groups for further
functionalization.

Figure 2.12 Fluorescence turn-on strategy for glucose detection based on combination
of Carbon nanodots supported on silver nanoparticles and GOx-mediated oxidation
of glucose. Reprinted with permission from [104], Copyright (2016) American
Chemical Society. (Permission in Appendix 12)
A fluorescence turned-on strategy for glucose sensing was achieved by incorporating
fluorescent carbon dots inside plasmonic silver nanoparticles shown in figure 2.12. [104]
Fluorescent carbon dots were first incorporated inside the plasmonic silver nanoparticles
during the synthesis silver nanoparticles. The glucose was oxidized by glucose oxidase and
produced gluconic acid and H2O2. The hydrogen peroxide etched silver nanoparticles and
consequently the inclusion of carbon dots were released. The advantage of this glucose
nanobiosensor is the high biocompatibility of carbon dots and silver nanoparticles.
Analytical results showed a linear response to glucose concentration at the range of 2
µM−10 µM.
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2.4.6

Graphene Nanomaterials

Some nanomaterials were fluorescence quenchers, like noble plasmonic gold/silver metal
nanoparticles and graphene/graphene oxide etc. In the glucose analysis process, these
fluorescent interacting nanomaterials could quench the fluorescent component through the
non-radiative transfer of electronic excitation energy to the π electron system of graphene.
When glucose is introduced, the fluorescence would be either turned on or turned off
depending on the sensor design. Reduced graphene oxide (RGO) or graphene oxide (GO)
are widely used in the glucose sensing assay. Pure graphene is difficult to be stabilized and
functionalized. Reduced graphene oxide or graphene oxide are more prevalently studied.
RGO and GO have good water solubility and are also biocompatible, which favor their
application in biosensing areas. [105-110] RGO/GO offer a large surface area and could
be functionalized by various groups or decorated with various nanomaterials. The original
existing carboxylic groups, epoxy groups and carbonyl groups on RGO/GO plane provide
the anchoring place for further chemical modifications with molecule and biomolecule or
other nanoscale materials. [111-113]
In summary, the above discussed fluorescent nanomaterials of semiconductor quantum
dots, dye-doped silica nanoparticles and upconverting nanomaterials are mostly
investigated and used in fluorescent glucose nanobiosensing. Besides that, fluorescent
quenching nanomaterials like plasmonic gold/silver nanoparticle, graphene/graphene oxide
nanomaterials are also heavily involved and used as fluorescence quenching components
in the glucose nanobiosensing assays.

2.5 Magnetoresistive Nanomaterials
Magnetoresistance is a spin effect. Spin up electron and spin down electron scatter at the
magnetic structures. The more scattering of the path, the larger resistance it has. Magnetic
nanomaterials and non-magnetic conductive metals like Cr, Cu etc. are sandwiched or
mixed as multilayer and/or multicomponent formats in nanoscale to form a
magnetoresistive chip. Magnetoresistive biosensors has been developed by several
research groups to sense proteins, antibody, antigen etc. [114-116] The Wang Group in
Stanford [117] has contributed greatly to magnetoresistive biosensors. They have
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developed a giant magnetoresistance (GMR) sensor arrays for quantification of protein
interactions and solution transport. [118] This GMR sensor chip is a multilayer
nanostructure, the target antibody were labeled with magnetic nanoparticle. They have also
developed another GMR sensor for multiplex proteins assay. [119] Wang’s group mainly
focus on protein sensing and assays. Other groups like Wang group of nanospin research
in University of Minnesota [120] has developed magnetoresistive biosensor for ion sensing,
[121] influenza virus sensing etc. [122] The magnetoresistance biosensor are promising for
future clinical applications. To our best knowledge, no glucose magnetoresistance
biosensor has been developed yet. Therefore my work on the magnetoresistive
nanostructured glucose biosensor is novel and important to MR biosensor development.
Graphene/magnetic nanoparticle composites are novel format for developing the
magnetoresistive biosensor. Graphene or reduced graphene oxide are conductive and have
no or very weak magnetic properties. The magnetic nanoparticle/graphene systems have
been studied by several groups. [123-127] One study decorated magnetic FeNi3
nanoparticles onto graphene nanocomposites to obtain enhanced magnetoresistance of
pressed pellets of graphene/FeNi3 nanoparticle composites. [128] An iron oxide/graphene
oxide nanocomposite based magnetoresistive random access memory device was
developed by Wee et al. [129] Therefore, magnetic carbon nanomaterials are promising for
developing magnetoresistive biosensors.

2.6 Summary
In glucose nanobiosensing, biocompatibility and enhanced fluorescent properties are the
major developing trends for highly sensitive and selective nanostructured biosensor. Most
of the investigated fluorescent nanomaterials have mature synthesis and surface
modification methods and superior fluorescent properties and they have been widely used
in glucose nanobiosensing.
For semiconductor quantum dots, its high quantum yield and photo-stability boost its
development. However the cytotoxicity of semiconductor quantum dots limits its clinical
in vivo application. In order to improve the biocompatibility of QDs, a biocompatible
coating layer is often applied to coat quantum dots before their further application in vivo
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and in vitro. Dye-doped silica nanomaterials have high biocompatibility. Example like
Cornell dots with high brightness and biocompatibility demonstrate the great potential for
the in vivo and in vitro applications of silica nanomaterials. And the silica matrix structure
and mesoporosity are facilely controllable. Moreover silica nanomaterials could be
modified with various chemical group and functionalization under the universal silane
chemistry. Encouragingly, the Cornell dots’ clinical human trial [130] and clinical
translation report [131] proved its biocompatibility and non-cytotoxicity effect for clinical
application. The upconversion nanomaterials (UCNPs) are very suitable for in vivo
applications in biosensing due to their high biocompatibility and superior upconverting
fluorescence characteristics (line like emission, long fluorescence lifetime and photostability). Plasmonic gold/silver nanoparticles are often used as fluorescent quenching
components, while fluorescent gold/silver nanoclusters are utilized as fluorescent
components. These plasmonic noble metal nanoparticles and noble metal quantum clusters
show high biocompatibility which have attracted intensive research in glucose
nanobiosensing applications.
Carbon nanomaterials represent a broad nanotools for applications in glucose
nanobiosensing. They have high biocompatibility, facile modification chemistry, facile
preparation, multiple choice of different carbon nanomaterials. Nanocarbon family
members have graphene/graphene oxide, graphene quantum dots, carbon dots, singlewalled/multi-walled carbon nanotubes, carbon nanodiamonds and carbon nanohorns etc.
They could be used as either fluorescent donor or fluorescence quenching acceptor in the
glucose nanobiosensor design. Moreover, nanocomposites of graphene/magnetic
nanomaterials are promising for constructing magnetoresistive nanostructures. Therefore,
carbon nanomaterials have gained more and more attention in the development of
nanostructured glucose biosensor.
Currently, the marketed electrochemical glucometer could provide accurate glucose
measuring. But this measuring require certain amounts of blood, the blood is often obtained
by finger prick. However the glucometer could only measure the blood glucose level at
that time. Therefore, several finger pricks are applied to diabetics per day. The pricks are
very uncomfortable for people and are susceptible to risks of infections. In a word, the
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prevalent glucometer is invasive to people but in the market there is barely alternative
available economic, minimally invasive or non-invasive glucose sensors for diabetics.
Nanomaterials and nanostructures could have novel chemical, physical and biological
properties. Nanostructured biosensors have high sensitivity and selectivity and are
promising for developing minimally invasive or non-invasive glucose sensors. Especially
the fluorescent and magnetoresistive nanomaterials and nanostructures are suitable for
development of minimally invasive or non-invasive glucose biosensor with high sensitivity
and selectivity.
In the long run, integrated nanostructured sensor chip device for continuous
fluorescence/magnetoresistance glucose nanobiosensing should be the major developing
strategy. Biocompatibility, stability, selectivity and sensitivity as well as economic benefit
are the major progressing considering parameters. These chips are promising to integrate
into in vitro nanostructured chips, microfluidics or semi in vivo contact lens and in vivo
implanted device with convenient data acquisition models for long termed, humanfriendly, real time, and dynamic measuring glucose levels in healthy people and diabetes
people. For the glucose sensing in food, pharmaceutical industries etc., the stability and
durability against all kinds of harsh environments like heat or cold, saline, acidic or basic
etc. need to be taken into considerations for long-termed usage of nanostructured glucose
biosensors.
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Chapter 3
This chapter reuses the published journal paper (Biosensors and Bioelectronics 2017, 91,
393-399.). Permission is in Appendix 13.

3 Development of ZnO/QD
Glucose Biosensor

Patterned

Nanostructured

3.1 Introduction
In this chapter, a nanostructured glucose biosensor was developed to detect glucose in rats'
tear by using fluorescence resonance energy transfer (FRET) quenching mechanism. The
designed FRET pair, including the donor, CdSe/ZnS core/shell structured quantum dots
(QDs), and the acceptor, dextran-binding malachite green (MG-dextran), was conjugated
to concanavalin A (Con A), an enzyme with specific affinity to glucose. In the presence of
glucose, the quenched emission of QDs through the FRET mechanism was restored by
displacing the binding dextran from Con A. To have a dual-modulation sensor (one module
is by fluorescence spectra and the other is by image pixel) for convenient and accurate
detection, the nanostructured FRET sensors were assembled onto a patterned ZnO nanorod
array deposited on the synthetic silicone hydrogel. Consequently, the concentration of
glucose detected by the patterned sensor could be converted to fluorescence spectrum with
high signal-to-noise ratio and calibrated image pixel value. The photoluminescence
intensity of the patterned FRET sensor increased linearly with increasing concentration of
glucose from 0.03 mmol/L to 3 mmol/L, which covered the range of tear glucose levels for
both diabetics and healthy subjects. Meanwhile, the calibrated values of pixel intensities of
the fluorescence images captured by a handhold fluorescence microscope increased with
increasing glucose. Four male Sprague-Dawley rats with different blood glucose
concentrations were utilized to demonstrate the quick response of the patterned FRET
sensor to 2 µL of diluted tear samples (2 µL rats’ tear mixed with 5 µL PBS solution).
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Tear fluid cleans and lubricates the eye while nourishing. Over 20 components have been
found in tears, including salt water, proteins, glucose, and some small metallic ions, etc.
[1] Diagnosis of biomolecules in tear fluid pertaining to ocular diseases such as ocular
rosacea, have been performed primarily by clinicians to examine the high molecular-mass
glycoproteins in tears. [2] The detection of ocular glucose dates back to 1930. [3]
Following that, Michail and his collaborators first demonstrated the level of glucose in
tears is often elevated in diabetic patients. [4] Sen and Sarin studied over 200 cases, their
statistic results indicated the blood glucose is about 2 times higher in diabetic patients than
that in non-diabetics, whereas tear glucose levels are about 5 times higher in diabetics than
that in the general population. [5] In past decades, different research groups found a definite
relationship between tear glucose and blood glucose, concluding hyperglycemia could be
detected by measuring tear glucose levels. [6-8] Recent studies indicate tear glucose mean
values were 0.35±0.04 mM and 0.16±0.03 mM, for patients with diabetes and healthy
subjects, respectively. [9] It is also noted that time lag in measuring tear glucose is common
to other glucose meters as it takes 5−15 minutes to allow the change of glucose in blood
to eventually reflect in tear/interstitial fluids; [10] while it could be solved by a series of
calibrations. [11-12]
However, it is very difficult to acquire enough tear samples in a short period. Furthermore,
the concentration of glucose in tears is much lower than that in blood. Very few methods
so far could measure such low concentration of glucose in a rapid fashion. [13-14]
Compared to many other techniques, fluorescence resonance energy transfer (FRET), an
inexpensive and very sensitive method, has been used in molecule imaging and glucose
test. [14-16] It is a distance-dependent energy transfer from a fluorophore donor (D) to a
fluorophore acceptor (A) in a nonradioactive process. When the distance of the two
fluorophores is very close (<10 nm), the excited D would transfer some of its energy to
excite A that then emits light at a longer wavelength. [17] Using FRET technique for
detecting the competitive reactions of glucose and other polysaccharide, such as dextran,
to Concanavalin A (Con A), a protein, may result in accurate and convenient measures.
[18-20] However, fluorophores/organic dyes used in FRET pair are subject to low
fluorescent intensity, and poor signal responses influenced by the decay of chromophores
and external environment. [21] Fluorescence nanostructures have been recognized as
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excellent materials used in FRET sensor due to their photo-stability and narrow emission
peaks. [22] We developed a nanostructured glucose biosensor by using fluorescence
resonance energy transfer (FRET) technique which was able to be incorporated into
hydrogel-based contact lens for measuring low concentration of glucose directly. [23-24]
While, most reported FRET sensors have an inversely proportional relationship between
I
the ratio of the fluorescence intensity of the donor to that of the acceptor ( D⁄I ) and the
A
amount of the targeted molecules because the rate constant of the energy transfer, k FRET,
decreases while the distance between the FRET pair increases. Consequently, most
reported FRET sensors have significant measurement errors when detecting the increase
of concentration of the targeted molecules because of the low fluorescence signal-to-noise
ratio.
Quite recently, fluorescent quenching-based assay in which the donor fluorescence could
be quenched by the acceptor without target analytes has shown significant advantages in
biosensing, as it allows the restored fluorescence signal proportional response to the
concentration of target analytes and lower background fluorescence. [16, 25]
Consequently, a new nanostructured sensor by applying FRET quenching mechanism was
developed here to detect small concentration of tear glucose from very small volume of
tear samples in a fast and accurate fashion.
Fig. 3.1 (a) displayed a FRET pair-labeled Concanavalin A (Con A), an enzyme with
specific affinity to glucose. [18-20] The donor in this designed FRET transducer was made
of quantum dots with an emission (λem) in the visible range; the acceptor was dextranbound malachite green (MG) which has an absorption at the same wavelength of the
emission of the quantum dots. The emitted fluorescence of the quantum dots could be
quenched by malachite green through the FRET mechanism. In the presence of glucose,
the binding between Con A and dextran was out competed by the affinity of Con A for
glucose. As a result, dextran-bound MG would not quench the fluorescence of quantum
dots, and therefore fluorescence intensity was restored. The change in fluorescence
intensity was correlated to the amount of glucose reacting with Con A.
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Figure 3.1 (a) Illustration of the designed FRET transducer made of Con Aconjugating quantum dots (donor) and MG (acceptor) for detecting glucose.
Competitive affinity for glucose displaces MG to restore the quenched fluorescence.
(b) Immobilization of the nanostructured FRET transducers on ZnO nanorod array
deposited on silicone hydrogel.
In addition, we would like to further develop a dual-method for detecting glucose through
both of fluorescence spectra and fluorescence images. To quickly and accurately detect the
amount of glucose in a very small volume of tear sample by measuring the changes of
fluorescence intensity of the sensor, the numerous nanostructured FRET sensors were
immobilized on a single ZnO nanorod (NR) which have a high surface area to volume ratio
as shown in Fig. 3.1 (b). This design allowed numerous FRET biosensors located at a
nanoscale, and therefore, was able to amplify the resolution of the sensor. [26] Moreover,
to quickly and accurately detect the amount of glucose in a very small volume of tear
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sample by fluorescence images, the designed pattern made of ZnO NR array was utilized
here which could be recognized easily through fluorescence image process. The pixel
intensity values in a taken fluorescence image corresponding to the concentration of
glucose could be calculated through an imaging process. Consequently, the patterned
nanostructured FRET sensor on silicone hydrogel could realize the dual modulation for
monitoring glucose level in tear samples through both of fluorescence spectrum and
calibrated image pixel value.

3.2 Experimental
3.2.1

Synthesis of CdSe/ZnS Core Shell QDs

Cadmium selenium/zinc sulfide (CdSe/ZnS) core-shell quantum dots (QDs) were chosen
as the donor of the FRET pair. The core-shell QDs were further functionalized with amine
groups. [27] Selenium precursor prepared by dissolving 0.79g selenium powder in 10 mL
trioctylphosphine (TOP). In one flask, 0.46g Cadmium Acetate dissolved in 10 mL TOP
and heated to 100 °C under argon for 1 hour. Selenium precursor injected and allowed to
stay at 80 °C. In another flask, a mixture of 20g TOPO, 10g hexadecylamine (HAD), and
5 mL TOP was heated 120 °C under vacuum for 2−3 hours. Mixture further heated to 340
°C under argon protection (slowly purge argon before heating). Once the mixture was
heated to 340 °C, inject the precursor solution (20g TOPO, 10g hexadecylamine (HAD),
and 5 mL TOP) inside the reaction. Temperature will decrease to 240 °C. Maintain the
temperature for 5 min for 655 nm QDs. Remove heating mantle and cool reaction down to
room temperature. Purify the CdSe QDs by adding excess methanol.
Mixture of hexadecylamine (HAD) (4g) and trioctylphosphine oxide (TOPO) (8g) were
loaded into a 100 mL 3-neck flask and then degassed and heated to 180 °C. At 180 °C, the
purified CdSe particles (50mg) was dispersed in 2 mL chloroform and added to solution.
After the chloroform was completely pumped out, the flask was filled with argon gas.
Temperature of reaction was then increased to 180−185 °C. Mixture of zinc acetate (54mg)
and bis(trimethylsilyl)sulfide (0.05mL) was dissolved in 1.0 mL TOP and 1mL oleylamine.
Then it was injected drop-wise for 5−10 min. After the injection, mixture was stirred for
1 hour at 180−185 °C. Solution was then cooled down to room temperature and the
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particles were purified using chloroform and methanol.Collect and purify using 3 fold
centrifugation and redispersion with methanol at 8000 rpm for 15 min.
Briefly, CdSe/ZnS (20 mg) dissolved in 3 mL of chloroform was mixed with a solution of
cysteamine (Cys) hydrochloride (100 mg) dissolved in 5 mL of water. The solution was
sonicated until the chloroform layer became clear. The remaining cysteamine was reacted
with the addition in excess of 2-mercaptoethanol (20 mmol/L). CdSe/ZnS/Cys QDs were
purified by threefold centrifugation (15 min at 10000 rpm) and rinsed with ethanol. Purified
particles were re-dispersed in water.

3.2.2

Preparation of ZnO/Silicone Hydrogel

Silicone hydrogel with 150 µm in thickness was produced using a photochemical process.
[28] In a small 20mL glass bottle, add in sequence as N,N-dimethylacrylamide (0.86 mL),
3-[tris(trimethylsiloxy)silyl]propyl methacrylate (1.72 mL), macromer bis-alpha,omega(methacryloxypropyl) polydimethylsiloxane (0.42 mL), 1-vinyl-2-pyrrolidinone (0.18
mL), ethylene glycol dimethacrylate (15 µL), and add 0.3 mL absolute ethanol for better
dissolve the chemicals. Then introduce Nitrogen or Argon into the solution for about 10
min. Then add 8mg diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide and add 0.1 mL
absolute ethanol to dissolve the powder, add the solution into the Nitrogen degassed
solution and keep on the Nitrogen for another 5 min. The solution is ready for ultraviolet
to initiate the polymerization process. Set up the glass reactor by using a piece of glass and
a piece of hard paper, exploit the transparent adhesive tape to rap the glass and the paper
well, add 4 binder clips to hold the structure and add the solution into the gap, then put it
into the ultraviolet oven for 50 min photo polymerization. The gel is washed with deionized
water.
A well-aligned ZnO nanorod array was grown on hydrogel through modifying a previously
reported method. [29] Briefly, zinc acetate dehydrate (0.01 M) was dissolved in 100 mL
ethanol as a seed solution. The seed solution was dropped on a hydrogel substrate
repeatedly followed by a heat treatment at 100 °C for 1 hour. The ZnO seed-coated
hydrogel film was then immersed in a mixed solution of zinc nitrate hexahydrate (0.025
M) and hexamethylenetetramine (HMTA; 0.025 M) in 200 mL of distilled deionized water.
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After heating at 90 °C for 3 h, the ZnO nanorod array was grown on the hydrogel. Samples
were rinsed with distilled deionized water and dried at room temperature.

3.2.3
Fabrication Patterned QDs Decorated-ZnO NRs Array on
Silicone Hydrogel
The patterned ZnO nanorod (NR) array was fabricated on the silicone hydrogel by a liftoff process (figure 3.2). The surface modification of the patterned ZnO NR array with
amino groups was described as follows; the ZnO NR array on silicone hydrogel was
immersed into 2 mL DMSO and 270 µL 3-aminopropyltriethoxysilane (3-APS)
suspension. After having reacted at 120 °C for 2 h, the ZnO hydrogel was taken out and
washed with ethanol to remove unreacted compounds. [30-31] Please note that a small
corner of the ZnO NR array on silicone hydrogel was not modified by 3-APS for further
conjugation of FRET pair which would be used as a control area for imaging analysis.

Figure 3.2 A lift-off process for fabricating the patterned ZnO nanorod array on
silicone hydrogel.
The lift off process is described here. Photoresist (PR) (Shipley 1827) was deposited on
the ZnO NR arrays by spin coating and the PR was UV (Karl Suss MJB3, Hg Arc Lamp)
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irradiated over a patterned photomask for 30 seconds followed with post-baking. After the
post-baking, the non-irradiated area was treated with a developer (Shipley Microposite
MF-319) for 2 minutes treatment and rinsed with DI water. A wet chemical etching method
was used to remove the ZnO area without PR by immersion in a diluted acetic acid solution.
After washing with DI water, the remaining PR was washed away using ethanol. The final
products were dried for further application.
Prior to coating QDs-based FRET sensor onto the surface of lithographically patterned
ZnO NRs, glutaraldehyde first reacted with amino group modified ZnO NRs. Following
that, ZnO NRs array on silicone hydrogel merged in a 20 mL CdSe/ZnS solution for 3 days
at 4 °C, then washed with DI water to remove excess glutaraldehyde and CdSe/ZnS QDs.
The obtained film was dried in the dark under vacuum to preserve sensing capabilities.

3.2.4

Synthesis of Malachite Green Dextran

Malachite green (MG) isothiocyanate and 70,000 MW amino-dextran purchased from Life
Technologies (Burlington, Ontario, Canada) were mixed in a sodium bicarbonate buffer
with 0.05 M at pH 9.6. [32] Successful conjugation of the isothiocyanate and dextran to
form MG-dextran was verified by thin layer chromatography as shown in Fig. 3.3.
Concentration of MG-dextran (ε = 105 M-1cm-1 for malachite green at 621 nm) was
determined by UV/Vis.

Figure 3.3 Chromatography of the conjugation of MG to dextran.

66

The isothiocyanate and MG-dextran had an Rf value of approximately 1.0 and less than
0.25, respectively. Concentration of MG-dextran (ε=105 M-1cm-1 for malachite green at
621 nm) was determined by UV/Vis using the Beer-Lambert Law:
A = εlc
Where A is the absorbance,  the molar absorptivity, l the path length, and c the
concentration (mol/L).

3.2.5

Synthesis and Optimization of FRET Sensor

Briefly, the dropwise application of Con A bonded with MG-dextran to the surface of QDsdecorated ZnO NRs with the aid of glutaraldehyde. The weight ratio of CdSe/ZnS/Cys QDs
to Con A bonded with MG-dextran was 7:1. Non-conjugated Con A was rinsed off with
DI water.

Figure 3.4 FRET signal (fluorescence intensity) vs. the weight ratio of QDs to Con A
loading with acceptor.

67

The optimization ratio was described here. Con A protein was first loaded with MGdextran at a molar ratio of 4:1 MG-dextran to Con A in water and agitated for 2 hours.
Following that, glutaraldehyde was added to the above solution at 1:1 molar ratio and
agitated for another 2 hours. The conjugation of MG-dextran to Con A was verified by the
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). To ensure
maximum sensitivity in the presence of glucose, CdSe/ZnS quantum dots (QD) were
conjugated to Con A bonded with MG-dextran at weight ratios of 10:1, 5:1, 3:1, 2:1, and
1:1, respectively, to determine the degree of quenching and when an increase in QD weight
becomes negligible to the change in fluorescence. In this study, the weight ratio of the
donor (QDs) to enzyme (Con A) bonded with the acceptor (MG-dextran) was maintained
at 7:1. From the trend of the curve, it is going to reach a plateau after ratio of 9:1. After the
ratio of 7:1, the FRET signal is not enhancing much. Considering the signal and economy,
we chose the ratio of 7:1.

3.2.6

Sensor Measurement

10 µL of glucose in different concentrations at pH=7.0, 0.03 mmol/L, 0.05 mmol/L, 0.2
mmol/L, 0.75 mmol/L, 1 mmol/L, 2 mmol/L, 3 mmol/L, were dropped on the patterned
FRET sensors on silicone hydrogels with 30 seconds of interacting time. The fluorescence
response of the patterned FRET sensors on silicone hydrogels to different concentrations
of aqueous glucose were recorded by the fluorospectrometer at excitation wavelength (λex)
=490 nm. At least five independent measures were conducted to measure the response of
the sensor according to each glucose level. The standard deviation for each measured points
was also calculated.

3.2.7
Fluorescence Sensor Signal Converting to Image Pixel
Intensity
A USB powered portable digital microscope, MiScope, from Zarbeco (40X, pixels
640×480), was used to measure and digitally capture the fluorescence intensity of the 0.5
mg of glucose sensor conjugated onto ZnO NRs. 10 µL of various concentrations of
glucose was added; 0.03 mM, 0.05 mM, 0.2 mM, 0.75 mM, 1 mM, 2 mM, and 3 mM.
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Glucose was allowed to react with the sensor for 5 min prior to fluorescent measurement.
The donor molecule was excited with the UV light built into the MiScope.
The captured images were converted to RBG colors using Matlab as our previous reported
results. [24] Both green and red channels were applied to record the pixel intensity pixel
values. The values of pixel intensity of the patterned sensors responding to glucose
amounts were calculated in comparison with that of the control areas where no FRET pair
was conjugated. The recorded fluorescence images taken by the handhold fluorescence
microscope could be converted to the value of pixel intensity through Matlab’s imaging
process. In this imaging conversion process, the image matrix of the control area were used
to compare with that of sensing area of the FRET sensor to obtain the value of pixels
intensity corresponding to the concentration of glucose. The captured FRET sensing image
with pixels ∑ XY is calibrated in comparison with the image of the control area (lowest
fluorescence signal from substrate) with pixels ∑ X′Y′. The calibrated pixel intensity (Ip)
generated from FRET sensors could be expressed as follow;
IP = ∑ I(Xi Yi ) − ∑ I(Xi′ Yi′ )
Where, i is the number of pixels in the chosen areas.

3.2.8

Cellular Viability

Cellular viability of the glucose biosensor was conducted in the Lab of Dr. David Litchfield
in the Department of Biochemistry of the University of Western Ontario. UTA-06 human
osteosarcoma cells were used in this work, which were derived from the human
osteosarcoma cell line U2-OS. The cell line was a generous gift from Dr. Christoph Englert,
Forschungszentrum Karlsruhe, Germany. This assay could provide a model to test the
cytotoxicity of the sensor.
UTA-06 cells were cultured and grown under sterile conditions in Dulbecco's Modified
Eagle Medium (DMEM) supplemented with 10% FBS and 100 units/mL penicillin and
100 µg/mL streptomycin, kept at 37 °C with 5% CO2. 250 000 cells were transferred into
each well of a 24 well culture plate and incubated overnight to ensure adhesion to the plate.
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Various amounts of patterned nanostructured FRET sensors (QDs-based FERT sensors
assembled on ZnO NRs), i.e. 0.03 mg, 0.07 mg, 0.10 mg, 0.15 mg, deposited on the surface
of silicone hydrogels with dimensions 1 cm ×1 cm. Samples were sterilized under UV for
10 minutes.
In quadruplicate, the UTA-06 cells were cultured with the above sensors deposited on
hydrogel samples for 24 hours. After the incubation period the sensor samples were
removed, and a MTT cell viability assay was performed. The absorbance of the plates was
measured at λem=490 nm, and the relative cellular viability was calculated.

Figure 3.5 Relative cell viability vs. the amount of the patterned FRET sensors
deposited on silicone hydrogel.
Figure 3.5 indicates relative cell viability ([Cr/Co] 100%) vs. the amount of patterned FRET
sensors on silicone hydrogel. The relative cell viabilities (%) of UTA-06 human
osteosarcoma cells treated by patterned nanostructured FRET sensors are correspondingly
normalized to the control sample. Here, Co is the viable cell numbers of the control sample
(bare silicone hydrogel), and Cr the viable cell numbers treated with the patterned FRET
sensors. The error bars were the calculated standard deviation.
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3.2.9

Animal Tear Test

This part was cooperated with Dr James Melling lab (Kinesiology, UWO). Following the
positive results of cytotoxicity (figure 3.5), we conducted the animal test to evaluate the
response of designed sensor to tear glucose. Four male Sprague-Dawley rats (Charles River
Laboratories, St. Constant, QC, Canada) were housed in a 12-h light/dark cycle room with
humidity (50%) and temperature (21.5 °C) kept constant. Rats were given water and chow
ad libitum and made diabetic with streptozotocin (STZ; Sigma-Aldrich, Oakville, ON,
Canada). Intraperitoneal injections of STZ (20 mg/kg) dissolved in a citrate buffer (0.1 M,
pH 4.5) were given over five consecutive days. Following the confirmation of diabetes
(two blood glucose readings larger than 18 mmol/L) subcutaneous insulin pellets were
implanted in the abdominal region of rats. Rats were anesthetized with isoflurane for ease
of application of the sensors to their eyes. Tear fluid was collected from the ocular surface
with a 1 µL glass capillary tube (P1424 SIGMA). 2 µL of rat tear sample were collected
from each male Sprague-Dawley rats. All samples were diluted by PBS (5 µL) with pH=7.0
into 7 µL total volume. Diluted tear samples (2 µL) were then dropped on the FRET
sensors. The standard deviation for each measured points was also calculated.
Fluorospectrometry was used to measure the fluorescence intensity of quantum dots
(donor) after tear samples interact with FRET sensor for 30 seconds. A blood sample was
taken from the saphenous vein concurrently with the application of the sensor for blood
glucose concentration (Freestyle Lite Blood Glucose Monitoring System, Abbott Diabetes
Care Inc., Mississauga, Ontario). Ethics approval was obtained through the University of
Western Ontario Research Ethics Board, in accordance with Canadian Council on Animal
Care guidelines.

3.3 Results and Discussion
3.3.1
Characterization of Nanostructured FRET Sensor Deposited
on Silicone Hydrogel
The ZnO NR array pattern was fabricated on the silicone hydrogel using it as a substrate
by a lift-off process shown in figure 3.2. SEM was used to study the patterned ZnO NR
array deposited on the synthetic silicone hydrogel as shown in Fig. 3.6 (a) and (b). The
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designed pattern is made for easy identification of the captured fluorescence images to
calibrate the pixel intensity depending on the concentration of glucose.

Figure 3.6 Characterization of nanomaterials by electron microscopes. (a) SEM
micrographs of patterned ZnO NRs deposited on a silicone hydrogel. The small inset
is the photomask. (b) The magnified SEM micrograph of ZnO nanorod array
deposited on a silicone hydrogel. (c) SEM micrograph of ZnO nanorods. (d) SEM
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micrograph of QDs coated ZnO nanorods. (e) TEM micrograph of QDs coated ZnO
nanorods. (f) HRTEM of CdSe/ZnS QDs.
The patterned ZnO NR arrays grown on the synthetic silicone hydrogel were modified with
amino groups (−NH2) to immobilize CdSe/ZnS QDs onto the ZnO NRs. Glutaraldehyde
first reacted with −NH2 functionalized ZnO NRs following the linkage formed by the
reaction of glutaraldehyde with the amino group modified QDs. In Fig. 3.6 (c), the
hexagonal rods with a smooth surface were grown on the silicone hydrogel. The average
dimensions of the ZnO NRs are estimated at 120±5 nm in diameter and 2.00±0.05 µm in
length. The rough surface of the NRs could be observed when decorated with QDs, as
shown in Fig. 3.6 (d). Furthermore, the TEM micrograph (Fig. 3.6 (e)) clearly shows the
QDs are decorated on the ZnO NRs. The HRTEM micrograph (Fig. 3.6 (f)) further
indicates the core-shell CdSe/ZnS QDs with 5±2 nm in diameter are decorated on the
highly crystalline ZnO NRs with a lattice fringe of 0.255 nm, which corresponds to the
(0002) lattice planes. [33]

Figure 3.7 FTIR spectra of the cysteamine (Cys) modified QDs and ZnO nanorod
(NR), and the hybrid ZnO NR coated with QDs (ZnO NR-QDs).
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Fig. 3.7 shows the FTIR spectra of the ZnO NRs with surface modification, amino modified
QDs, and the hybrid ZnO NRs coated with QDs (ZnO NR-QDs). All samples demonstrate
the typical −CH stretch, and −CH2 stretch in the FTIR spectra. The −C=O stretch at 1750
cm−1 is observed when glutaraldehyde was modified onto ZnO NRs, while this stretch does
not show up to sample of ZnO NR-QDs. The −C=N stretch of the imine group, and
−C=N−R located around 1620 cm−1 appears in the spectrum of ZnO NRs-QDs. Thus, two
carbon-nitrogen double bonds (C=N), i.e. Schiff bases, were formed to allow QDs to coat
on the ZnO NRs through the linkage of glutaraldehyde.

3.3.2
Fluorescence Intensity of the FRET Sensor as a Function of
Glucose Level in Aqueous

Figure 3.8 Photoluminescence of ZnO NR arrays on silicone hydrogel with/without
QDs, and QDs-based fret sensors, and the UV-vis absorption of MG.
The optimization of the weight ratio of the donor (QDs) to enzyme (Con A) bonded with
the acceptor (MG-dextran) was determined at 7:1 as shown in the figure 3.4. The
photoluminescence (PL) properties of the nanostructured FRET transducer-coating ZnO
NR array (i.e. the patterned FRET sensor), the nanostructured donor of the sensor (i.e.
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CdSe/ZnS QDs) were studied by a fluorospectrometer in the range of 550−700 nm. In Fig.
3.8, the photoluminescence (PL) spectrum of ZnO in the visible range is observed with
centering at 628 nm.
The maximum intensity of PL spectrum of CdSe/ZnS QDs is observed at 648 nm. The PL
spectrum of ZnO NR-QDs is dominated by the decorated QDs because of the large amount
of QDs on a single ZnO NR, centered at 648 nm. When the acceptor of FRET sensor, MGdextran, bound to QDs through Con A, the PL peak of ZnO NRs could be observed with
centering at 652 nm; whereas the PL peak at 652 nm attributed to the donor (QDs) of the
patterned FRET sensor is significantly suppressed. The slight redshift of the emission of
QDs may be caused by the surface conjugation of Con A and the acceptor of MG-dextran.
MG quenches the fluorescence signal of QDs through the FRET mechanism because of its
broad absorbance around 655 nm.

Figure 3.9 A linear relationship between fluorescence intensity of the designed sensor
and the concentration of glucose.
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10 µL of aqueous glucose of various concentrations were dropped onto the patterned FRET
sensors on silicone hydrogels with 30 seconds of interaction time. The fluorescence
measurements were determined by fluorospectrometry. As shown in the illustration of Fig.
3.1, the fluorescence emission of the donor (CdSe/ZnS QDs) of the designed FRET sensor
was quenched by the acceptor MG. In the presence of glucose, the quenched fluorescence
of QDs is restored after the addition of glucose and the fluorescence emission of the
patterned FRET sensors centered at 652 nm increases with increasing aqueous glucose.
The FRET emission (λem=652 nm) as a function of the concentration of aqueous glucose
were measured. The relative fluorescence intensity (Ire) is calculated by using the equation
below;
Ire =

I′
Io

Where, I′ is the restored intensity according to a glucose level, Io is the intensity of the
sensor without glucose. Fig. 3.9 shows that two linear regions; (1) from 0.03 mM to 3 mM;
and (2) from 0 mM to 0.03 mM. It is noted that the concentration of glucose in the range
of 0.03 mM−3 mM could cover the tear glucose lever of both the diabetes and healthy
subject. The linear relationship between relative fluorescence intensity and glucose
concentration in the range of 0.03 mM−3 mM could be expressed as follows;
Y = 0.239X + 1.132

3.3.3
Pixel Intensity Value of Fluorescence Image of FRET Sensor
as a Function of Glucose Level in Aqueous
The fluorescence images of the patterned FRET sensors on silicone hydrogel interacting
10 µL of various concentrations of aqueous glucose were monitored by a handheld
fluorescence microscope. Fig. 3.10 (a) shows two fluorescence images of the patterned
FRET sensor interacting with two samples of aqueous glucose; 0.04 mmol/L (sample A)
and 0.4 mmol/L (sample B). The recorded images by the handheld microscope were
converted to the readable signal through Matlab's imaging process. The pixel intensity was
calibrated using MatLab to plot the intensity as a function of aqueous glucose
concentration. The calibrated pixel intensities of the patterned FRET sensor is clearly
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increasing as glucose increases from 0.03 mmol/L to 0.6 mmol/L as shown in Fig. 3.10 (b).
The difference in pixel intensity value does not change significantly when the
concentration of glucose is beyond 0.6 mmol/L. It is expected that a more advanced
fluorescence microscope would be able to overcome the limit.

Figure 3.10 Fluorescence images of the patterned FRET sensor on silicone hydrogel
and the relative pixel intensities of the sensors responding to the concentrations of
glucose. (a) Fluorescence images of the patterned FRET sensor to aqueous glucose
with 0.04 mmol/L and 0.4 mmol/L, respectively. (b) The relative pixel intensities of
the sensors vs. the concentration of aqueous glucose.

3.3.4

Response of Designed FRET Sensor to 2 µL Rat Tears

The concentrations of blood glucose of the rats used in the current study were maintained
in a range similar to patients with ‘poorly’ managed Type 1 diabetes. [34] Specifically, rats
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were representative of low to moderate hyperglycemic patients with Type 1 diabetes
mellitus under conventional insulin therapy. [35] Typically blood glucose concentrations
in patient populations with type 1 diabetes fluctuate considerably; therefore, four rats with
a range of blood glucose concentrations were utilized in the experiment to demonstrate.
The photoluminescence spectra of the patterned FRET sensor deposited on silicone
hydrogels corresponding to the diluted rats’ tear samples (2μL) could be seen in Figure
3.11 after interacting with rat tears.

Figure 3.11 Photoluminescence spectra of designed sensor responding to tear samples
from rats with different glucose level in blood.
The rats’ tear samples were diluted 3.5 times. The patterned FRET sensor deposited on
silicone hydrogels were used to measures the 2 µL diluted rats’ tear samples. The PL
spectra of the sensor corresponding to glucose in tears are shown in Fig. 3.11 after
interacting with rat tears. The detected glucose level in rats’ tear samples were calculated
by using Eq. Y=0.239X+1.132. Meanwhile, the blood glucose levels to the four rats were
measured by Freestyle Lite Blood Glucose Monitoring System, Abbott Diabetes Care Inc.
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Table 3.1 shows the glucose level in rats’ tear samples measured by the nanostructured
FRET sensor as compared to the blood glucose level of the four rats. The small value of
the calculated standard deviation of the measurement indicates the repeatability of the
measure.
Table 3.1 Glucose level in rats’ tear samples measured by the nanostructured FRET
sensor as compared to the blood glucose level of the four rats.

3.3.5

Blood glucose (mmol/L)

Tear glucose (mmol/L)

5.3

0.14±0.03

9.7

0.42±0.04

12.3

0.95±0.05

18.2

1.28±0.05

Selectivity of Designed FRET Sensor

Figure 3.12 Relative sensing signal (Itest sample/Iglucose) to different biomolecules.
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The selectivity of the designed sensor towards glucose detection was further verified. 1
mM glucose in PBS solution and some possible interfering molecules, sucrose, fructose,
mannose, lactose, maltose, mannitol, histidine, cysteine, ascorbic acid, and cholesterol at
1 mM, were tested by the designed sensor, respectively. The relative sensing signal is
referring to the normalization of the fluorescence intensity of the designed sensor
responding to 1mM test sample to the sensor’s fluorescence intensity in the presence of 1
mM glucose (Itest sample/Iglucose). Figure 3.12 suggests that the designed sensor has a high
selectivity to glucose.

3.4 Conclusion
In summary, the patterned nanostructured FRET sensor deposited on the synthesized
silicone hydrogel were designed for monitoring glucose in tears. The emission (λem)=655
nm of the CdSe/ZnS QDs could be quenched by the acceptor of dextran-bound malachite
green (MG) which has an absorption at the same wavelength of the emission of the QDs.
The dual modulation of detection is realized by depositing CdSe/ZnO QDs-based FRET
sensors on the ZnO nanorod array. When the interaction time was maintained at 30
seconds, a linear relationship of the photoluminescence of the patterned nanostructured
FRET sensor to the concentration of glucose from 0.03 mmol/L to 3 mmol/L is observed.
It is noted that the tear glucose of diabetics is>0.35±0.04 mmol/L, and the average value
of tear glucose for healthy subjects is around 0.16 ± 0.03 mmol/L. Meanwhile, the
calibrated values of pixel intensities are increasing with increasing glucose from 0.03
mmol/L to 0.6 mmol/L. Four rats with a range of blood glucose concentrations were
utilized in the experiment. The results clearly show that the patterned nanostructured FRET
sensor is capable of quickly monitoring tear glucose in an extremely small drop (2 µL) of
tear sample. Consequently, our designed nanostructured FRET glucose sensor is suitable
for monitoring tear glucose in a non-invasive and quick manner.
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Chapter 4
Part of this chapter reuses part of the published journal paper (RSC Advances 2017, 7 (43),
26770-26775.). Permission is in Appendix 14.

4 Development of Upconversion NaGdF4: Yb, Er Glucose
Biosensor
4.1 Introduction
In this chapter, a one-pot process was developed to produce NaGdF4: Yb, Er upconversion
nanocubes (UCNCs) with amine group surface modifications. The amine groups facilitated
further surface conjugation of upconverting nanomaterials. After sufficient conjugation of
the amine groups and suitable PEGylation, the adsorption of other proteins could be
effectively avoided. The upconverting nanomaterials were used to fabricate an
upconverting nanostructured glucose biosensor. The photoluminescence and magnetic
properties of the amine modified unpconversion nanocubes (UCNCs) were investigated.
The emissions of green light at 541 nm and red light at 655 nm were observed under nearinfrared excitation (λex=980 nm). In addition, the magnetic susceptibility of the nanocubes
was 1.049×10-4 emu·g-1·Oe-1 at room temperature, which was 29 % larger than the reported
value. NIH/3T3 mouse fibroblast cell line was used to study the cytotoxicity of the UCNCs.
The produced UCNCs with surface modification did not impose toxic effect on cells. Then,
a nanostructured glucose biosensor was constructed based on this upconversion
nanomaterials.
Upconversion nanoparticles could convert excited light with a lower energy into emission
light with a higher energy because of the multiphoton excitation-involving nonlinear
process, which could be applied in various areas, including luminescent display devices,
optical devices, photo-therapy, and medicine, etc. [1-4] Most studies indicated that the
dopants of lanthanide, such as Er, Tm, and Ho, could produce emission as the optically
active centres due to the 4f–4f orbital electronic transitions. Fluoride materials, e.g. NaYF4
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and NaGdF4, normally act as the excellent host lattices because of their high chemical
stability and good optical transparency over a wide wavelength range. [5-6] Unique
properties of lanthanide-doped upconversion nanomaterials have attracted extensive
attention, e.g. optical-magnetic bi-functional properties of NaGdF4: Yb, Er. [7-8]
Various methods have been developed to produce upconversion nanocubes (UCNCs),
including hydro(solvo)-thermal reaction, thermal decomposition of rare earth organic
precursors, and ionic liquids methods etc. [9-11] Hydro(solvo)-thermal reaction and
thermal decomposition could produce highly crystalline and monodispersed nanocubes,
while the reactions need highly controlled reaction parameters, e.g. temperature, and toxic
organic rare earth precursors which bring barriers to further modification for biomedical
applications. Whereas, the ionic liquids-related methods yield less uniform nanocubes, but
are relatively easy to control the process parameters. [12-13] Therefore, facile synthesis
strategies for high-quality UCNCs with controlled composition, crystalline phase, particle
size, are highly demanded. [14-15]
On the other hand, studies show that fluorescence properties of upconversion nanoparticles
could be affected by energy levers of rare earth ions, the surface modification, etc. [16-17]
Riman and his co-workers reported that the effects of three different surfactants;
trioctylphosphine, polyethylene glycol monooleate, and polyvinylpyrrolidone on the
emissions of NaYF4: Yb3+, Er3+ nanomaterials. The emission intensity of NaYF4: Yb3+,
Er3+ dried powder decreased following the order, polyvinylpyrrolidone > polyethylene
glycol monooleate > trioctylphosphine > unmodified nanoparticles because of the reduced
reflectance loss at the boundary between upconversion nanoparticles with different
surfactants and the air. Song et al. [18] reported that NaYF4: Yb3+, Er3+ nanoparticles
modified with thioglycolic acid could transfer hydrophobic upconversion nanoparticles
into hydrophilic upconversion nanoparticles. And the results indicated that the blue
emission (2H9/2→4I15/2) and red emission (4F9/2→4I15/2) with respect to the green emission
(2H11/2, 4S3/2→4I15/2) have been enhanced after surface modification.
In this chapter, we developed a modified solvothermal method to have a one-pot synthesis
of NaGdF4: Yb3+, Er3+ UCNCs with amine surface modification. It is noted that amine
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functional group normally increases the hydrophilicity of nanomaterials, and is useful for
further conjugating to different molecule. In order to avoid the amine groups interaction
with other proteins. We deposited these upconversion nanoparticles onto silicone hydrogel
surface and modified with a layer of PEGylation. As gadolinium-based upconversion
nanomaterials could be used as a dual contrast agent and fluorescence imaging. The
fluorescence and magnetic properties of the UCNCs with surface modification were
investigated. The cytotoxicity of the produced UCNCs was also investigated for potential
applications in bio-imaging.
With over decades’ efforts, tear glucose is considered as a biomarker for diagnosis of
diabetes. [19-20] The mean values of tear glucose were measured at 0.35 mM±0.04 mM
and 0.16 mM±0.03 mM, for patients with diabetes and healthy subjects, respectively. [21]
Most commercialized glucose meter is used for detecting glucose in bood with the testing
range from 3 mM to 25 mM. The difficulties on using this tear glucose lies in quickly
collecting enough tears for test, and accureatly measuring such low concentration of
glucose in tears. Here, we demonstrated that a nanostructured biosensor deposited on
silicone hydrogel substrate could be used to detect rat’s tear glucose in vivo. The designed
biosensor was composed of protein (Con A) conjugated upconvension nanoparticles
(UCNPs) incorporating with hydrogel, a contact lens materials.
Since Leonardo da Vinci introduced the concept of a contact lens in the year 1508, it has
been one of the most commonly worn biomedical devices in the 21st century. [22] Future
benefits of this wearable medical device from the developments of nanobiotechnology are
not limited in vision correction, but also are promising for the topical eye treatment. [2324] Quite recently, the engineered contact lenses for monitoring tear glucose was
recognized as a means for non-invasive diagnosis and monitoring for diabetics. [25-26]
Fluorescein eye stain test is common in eye exam. [27] Consequently, fluorescence sensors
incorporating contact lens may be used for wearing on eyes and detecting components in
tears directly. Small handheld fluorescent microscopy could be developed to measure the
contact lens fluorescent signal. Though the discrepancy in the correlation between tear
glucose and blood glucose were found caused by the collection methods and time lag in
tear measurement. [28-29] detection of tear glucose could provide a non-invasive method
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to be supplementary to the current blood glucose tests. Furthermore, glucose concentrations
in diabetic individuals in comparison to healthy individuals were found to be 4 times and
2 times higher when assessed in ocular tears and blood respectively. [29]
Luminescence resonance energy transfer (LRET) is a distance-dependent nonradioactive
process. When the distance of the two fluorophores is very close (< 10 nm), the excited
fluorophore donor (D) would transfer some of its energy to excite fluorophore acceptor
(A). [30-31] LRET pair-labeled enzyme sensors have been used in studying protein-protein
interactions. [32-35] Upconversion nanostructures are the emerging luminescent
nanomaterials, which have the unique capability to convert the excited light with a lower
energy to the emission light with a higher energy because of the multiphoton excitationinvolving nonlinear process. [12] In addition, upconversion nanostructures show
advantages over conventional fluorophores, including high signal-to-noise ratio, superior
photo-stability, and low toxicity. [36-39] In comparison, semiconductor quantum dots
require external excitation energies close to the ultraviolet range, which could result in
profound effects leading to photic damage. [40] The upconversion materials are excited by
lower frequency near-infrared radiation and emit higher energy radiation in the visible light
spectrum. Lanthanide-doped upconversion nanostructures show enhanced emission in the
visible region (400 nm < λem < 700 nm) with the near-infrared excitation wavelengths (700
nm < λex < 1200 nm). [41-42] The upconversion nanostructures utilizing near-infrared
radiation (760 nm to 1400 nm) are very ineffective in producing retinal injuries and
therefore much safer for ocular applications. [43-44]
Figure 4.1 showed the designed LRET sensor incorporating contact lens for detecting tear
glucose directly. Concanavalin A (Con A), an enzyme with specific affinity to glucose,
[45] was conjugated with the donor, NaGdF4: Er, Yb upconversion nanoparticles (NPs),
through two Schiff bases (C=N). The acceptor of the LRET sensor was dextran-binding
malachite green (MG) which has an absorption at the same wavelength of the red emission
of the NaGdF4: Er, Yb, upconversion NPs. The emitted fluorescence of the donor was
quenched by malachite green (MG) through the LRET mechanism. Dextran is a saccharide
with affinity for Concanalin A. [46] In the presence of glucose, the binding between Con
A and dextran could compete over by the binding between Con A and glucose. The most
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significant advantages of using upconversion nanostructures include: (1) the
nanostructures acted as an analyte (tear glucose) collector to achieve high concentration of
analyte reacting with the LRET enzyme sensor due to the large surface area to volume
ratio; (2) the nanostructures exhibited stable optical signals as shown in figure 4.1; and (3)
large surface-to-volume ratio of enzyme-immobilized nanostructures could lead to higher
selectivity for glucose sensing. The fluorescence intensity (I) of the LRET sensor as a
function of the concentration of glucose has been investigated thoroughly in vitro and in
vivo.

Figure 4.1 Schematic of LRET sensor sensing mechanism.

4.2 Experimental
4.2.1
Synthesis of Polyethylenimine (PEI) Modified Upconversion
Nanostructures
40±5 nm paramagnetic upconversion NPs were synthesized by polyol method. [47] In a
typical synthesize process, 1.6 mmol Gd(NO3)3·6H2O, 0.36 mmol Yb(NO3)3·5H2O, 0.38
mmol Er(NO3)3·5H2O, 0.7 g branched polyethylenimine (PEI), and 20 mL ethylene glycol
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were added into a 100 mL three-neck round-bottom flask and dissolved by magnetic
stirring. Then, 8 mmol NaF dissolved in 10 mL ethylene glycol were added dropwise into
the 100 mL flask. Under reflux, the solution was heated to around 198 °C to keep ethylene
glycol boiling for 6 hours under nitrogen gas protection. The as-synthesized upconversion
nanocubes were centrifuged and purified with ethanol and water several times, then dried
at 60 °C overnight.

4.2.2

Synthesis of Malachite Green Dextran

Malachite green dextran was synthesized according to the method by McCartney et al. [35,
46] In short, malachite green (MG) isothiocyanate and 70,000 MW amino-dextran
purchased from Life Technologies (Burlington, Ontario, Canada) were mixed in a sodium
bicarbonate buffer (0.05 M, pH 9.6). Successful conjugation of the isothiocyanate and
dextran to form MG-dextran was verified by thin layer chromatography. The
isothiocyanate and MG-dextran had an Rf value of approximately 1.0 and less than 0.25,
respectively (chapter 3 at section 3.2.2).

4.2.3

Conjugation of Glucose Sensor Components

In short, the Con A solution 1 mg/mL, 2 mL was conjugated to upconverting nanoparticle
1 mg/mL, 2 mL with 200 µL 0.5 % glutaraldehyde solution at room temperature for 2 hours
under mild ellipsoidal shaking. 10 mg malachite green-dextran was added and allowed to
bind to Con A for an additional 2 hours. The biosensor was collected after thrice
centrifugation for 5 minutes at 9000 rpm and resuspended in deionized water.

4.2.4

Sensor Deposition onto Silicone Hydrogel

As a medium to contain the upconverting nanoparticle glucose biosensor, we deposited
200 µL of the glucose sensor suspended in water solution onto pieces of silicone hydrogels
and put in 4 °C fridge to let dry. The hydrogel was sterilized by soaking in 75% ethanol.

4.2.5

In Vivo Animal Model

This part was cooperated with Dr James Melling lab (Kinesiology, UWO). Six male
Sprague-Dawley rats (Charles River Laboratories, St. Constant, QC, Canada) were housed
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in a 12-hour light/dark cycle room with humidity (50%) and temperature (21.5°C) kept
constant. Intraperitoneal injections of STZ (20 mg/kg) dissolved in a citrate buffer (0.1M,
pH 4.5) were given over five consecutive days were given to induce diabetes. Following
the confirmation of diabetes (two blood glucose readings greater than 18mM) subcutaneous
insulin pellets were implanted in the abdominal region of rats.
Ethics approval was obtained through the University of Western Ontario Research Ethics
Board, in accordance with Canadian Council on Animal Care guidelines.

4.3 Results and Discussion
4.3.1

TEM and XRD

Figure 4.2 (a) TEM micrograph of NaGdF4: Yb3+, Er3+ UCNCs, the small inset is the
size distribution histogram chart. (b) HRTEM image of as-synthesized NaGdF4: Yb3+,
Er3+ UCNCs.
TEM and HRTEM were used to characterize the as-synthesized NaGdF4: Yb, Er UCNCs.
Fig. 4.2 (a) showed the TEM micrograph of highly uniform nanocubes. The average length
of the nanocubes was approximately 40±5 nm. Fig. 4.2 (b) showed the HRTEM image of
as-synthesized upconversion nanocubes with highly crystalline structure. The measured
inter-planar distance between two adjacent lattice planes was 0.312 nm, corresponding to
the (1 1 1) plane of cubic phase NaGdF4 (JCPDS 27-0697).
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Figure 4.3 XRD profile of NaGdF4: Yb3+, Er3+ upconverting nanoparticles and the
line pattern of standard cubic phase of NaGdF4 (JCPDS 27-0697) and hexagonal
phase of NaGdF4 (JCPDS 27-0699).
The XRD profile was shown in Fig. 4.3. The XRD profile indicated that standard cubic
phase (JCPDS 27-0697) dominated in the crystal structures. [48] It was also noted that
there were two small peaks around 2 theta at around 30, which could be caused by the other
phase, hexagonal NaGdF4 crystal (JCPDS 27-0699). Compared to the thermal
decomposition for producing cubic UCNPs at high temperature over 300 °C, [8, 11] the
one-pot method utilized ethylene glycol polyol solution at 198 °C to produce PEI modified
upconverting nanoparticles. In addition, the dopants, i.e. Yb, and Er ions, normally would
not change the crystal structures, but may slightly change the lattice strain of the crystals.
Therefore, the characteristic peaks of cubic NaGdF4 crystal acting as the host have a slight
shift as compared to the standard cubic phase of NaGdF4 (JCPDS 27-0697) crystal
structure.

91

4.3.2

FTIR Spectrum of PEI Modified Upconverting Nanoparticles

Figure 4.4 FTIR spectrum of PEI capped NaGdF4: Yb, Er upconversion nanocubes.
The successful capping of as-synthesized upconversion nanocubes with PEI to
functionalize the surface with amine groups was confirmed by Fourier transform infrared
(FTIR) spectroscopy. The obtained FTIR spectroscopy was similar to previous results. [4951] As shown in figure 4.4, the broad peak at 3300 cm-1 was attributed to the −NH−
stretching. The small peak present at 1640 cm-1 was due to the −NH− bending. The peak
at 1500 cm-1 was the vibration of the amine groups. And peak at 1400 cm-1 was due to the
stretching vibrations of C−N bonds. [24] These results confirmed the successful binding
of PEI onto the nanocube surface.
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4.3.3

Upconverting Fluorescence

Figure 4.5 Photoluminescent spectrum of NaGdF4: Er, Yb solution (1 mg/mL). (a)
Photoluminescence as a function of laser light powered in the range of 0.5 W to 1.5
W. (b) Power dependence of red and green emissions.
The fluorescence spectra of the upconverting nanoparticles were shown in Fig. 4.5. Under
excitation at 980 nm, varied excitation density, two upconversion emission bands of green
light at 541 nm and red light at 655 nm were observed. The green light emission (λem=541
nm) was attributed to 4S3/2→4I15/2 electronic transition, while red light emission (λem=655
nm) was attributed to 4F9/2→4I15/2 electronic transitions. Emission features of the
synthesized upconversion nanoparticles were comparable to the reported results. [52-53]
The two emission bands observed at 541 nm and 655 nm were attributed to a two-photon
upconversion process.

4.3.4

Magnetic Properties Analysis

The magnetic properties of as-synthesized NaGdF4: Yb3+, Er3+ upconversion nanocubes
was measured with a Vibrating Sample Magnetometer (VSM). Fig. 4.6 (a) showed the
hysteresis loop of NaGdF4: Yb3+, Er3+ upconversion nanocubes under a magnetic field of
±10 kOe under various temperatures, 85 K, 125 K, 150 K, 200 K, 250 K and 295 K. The
UCNCs showed typical paramagnetic properties. [54-55]
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Figure 4.6 (a) Magnetic hysteresis curves of PEI capped NaGdF4:Yb3+, Er3+
nanocubes with temperatures. (b) Magnetic susceptibility of NaGdF4:Yb3+, Er3+
nanocubes at various temperatures.
The magnetic susceptibility (χ) of the UCNCs was calculated by using Curie law; [56]
χ=

M
H

Where M is the magnetization per weight, H is the magnetic field. Fig.4.6 (b) displayed
the χ value of the UCNCs as a function of temperature (T), which was a typical curve for
paramagnetic materials. At room temperature (295 K), χ value was 1.049×10-4 emu·g-1·Oe1

, which was 29% larger than the reported value of the NaGdF4: Yb3+, Er3+ upconversion

nanoparticles, ∼0.813×10-4 emu·g-1·Oe-1. [56-57] It increased with decreasing
temperature, when temperature was 85 K, χ value of the UCNCs was 3.361×10-4 emu·g1

·Oe-1, due to thermal fluctuation reduction at low temperatures. [58-59] Our produced

UCNCs exhibited paramagnetic properties. Therefore, the magnetization (M) normally
increased with reducing particle size as reduced particles size normally leaded to single
domain, or low internal energy barrier. [60] In addition, the cubic structure could allow the
nanoparticles to have easy magnetization along certain orientation, leading to the reduced
magnetic field for saturating UCNCs. Reports have demonstrated that suitable surface
modification could result in desired nanostructured in term of uniform particle size, and
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shape. [61] Thus, the stronger magnetic susceptibility of the produced UCNCs could be
related to their cubic structures, the small particle size, and surface modification.

4.3.5

Cytotoxicity Study

Figure 4.7 Relative cell viability as a function of the concentration of UCNCs with
surface modification.
NIH/3T3 mouse fibroblast cells were used for the cytotoxicity test. The cells without the
treatment of UCNCs was used as a control. The relative cell viability of UCNCs with PEI
modification were over 110% when the concentration of UCNCs increased from 5 to 40
μg mL−1, it decreased to 97.3% when the concentration of UCNCs increased to 100 μg
mL−1 as shown in Fig. 4.7. The relative cell viability for materials with good
biocompatibility was normally beyond 85%. [62] Therefore, the as-made UCNCs modified
with amine functional group did not impose toxic effect on NIH/3T3 mouse fibroblast cells.

4.3.6

Sensitivity of Sensor Construct to Detect Glucose in Solution

In order to monitor a broad range of glucose levels (0.01 mM to 10 mM) quickly, with a
high signal response, two different synergistic materials were used to avoid high external
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energy excitation of the LRET sensor; (1) NIR/IR excitable donor consisting of
upconversion nanomaterials, and (2) an acceptor molecule competitively binding with a
lectin protein with a high glucose affinity. NaGdF4: Er, Yb upconversion NPs modified
with Polyethylenimine (PEI) was conjugated to Concanavalin A (Con A) protein using
glutaraldehyde to covalently link the primary amino groups of the PEI and Con A. The
nanobiosensors were then loaded with malachite green-dextran.
The premise of our biosensor construct utilizes Luminescence Resonance Energy Transfer
(LRET) [30, 63] to monitor glucose levels as shown in figure 4.1. The donor molecule,
upconversion NPs, once excited by NIR/IR radiation would emit energy at a higher energy
than the initial excitation energy. In the absence of glucose, the malachite green-dextran
acceptor absorbs this energy to decrease the detected fluorescence. In the presence of
glucose, the malachite green dextran is competitively displaced from the Con A thus
increasing the fluorescence as a function of glucose concentration.

4.3.7

In Vivo Sensing of Glucose in Murine Tears

Four male Sprague-Dawley rats (Charles River Laboratories, St. Constant, QC, Canada)
were treated with streptozotocin (STZ; Sigma-Aldrich, Oakville, ON, Canada) to induce
diabetes. Rats were anesthetized with isoflurane for ease of application of the sensors to
their eyes. Tear fluid was also collected from the ocular surface with a 1 µL glass capillary
tube for reference. A blood sample was taken from the saphenous vein concurrently with
the application of the sensor for blood glucose concentration (Freestyle Lite Blood Glucose
Monitoring System, Abbott Diabetes Care Inc., Mississauga, Ontario).
The glucose sensor deposited on silicone was gently applied PEG side towards the murine
subject’s eye for 15 seconds and removed. Samples were measured by the
fluorespectrometery with excitation at 980 nm. Dynamic sensing are possible by
developing or incorporating products like Google Lens.

4.3.8

Contact Lens-like Material Incorporation of Glucose Sensor

Silicone hydrogel are more suitable as contact lens material in comparison to commercial
lens materials as they contain enhanced features. In addition to great biocompatibility,
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transparency, and stable chemical structures ideal for contact lens, the presence of siloxane
groups increases oxygen transmissibility. [64-66]
The upconversion glucose nanobiosensors were deposited onto the surface of silicone
hydrogels as a concentrated material droplet and allowed to dry. A uniform thin layer of
polyethylene glycol (PEG) was coated over the silicone surface with a method similar to
pulsed laser deposition to prevent dissociation of the sensor. [67-69]

Figure 4.8 SEM image of contact lens nanostructured glucose biosensor surface.
The as-synthesized PEI capped upconversion nanoparticles were surface functionalized
with amine group (−NH2). As a result, the polyethylenimine (PEI) capped upconversion
nanoparticles were well disperse in water. The successful surface modification by PEI was
confirmed by Fourier transform infrared (FTIR) spectroscopy (figure 4.4). The amine
group provides suitable opportunity to covalently adhere proteins through the use of
chemical functional groups such as hydroxyl and amine groups. These groups were
conjugated with Con A. In the tear, the present proteins could be avoided by applying the
PEGylation of sensor surface. Figure 4.8 presented the SEM image of nanostructured
glucose sensor chip surface. Some protein aggregates are present in the figure.
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As shown in Figure 4.9, the sensor deposited onto silicone showed a linear response to
plasma glucose with a R2=0.97 in the range of about 5 mM to 13 mM. Because the figure
has not yet been published, we will keep the error bars etc. data before published.

Figure 4.9 Nanostructured upconverting glucose biosensor response to plasma
glucose.

4.4 Conclusion
Our findings indicated upconversion nanomaterials are attractive as donor for noninvasive
glucose sensing in contact lens. Its ability to be excited at the NIR range not only improves
emission efficiency but ensures the safety of the retina. [43] The Con A protein
demonstrated a high affinity for glucose resulting in an immediate change in fluorescent
intensity with a linear response in a laboratory setting. Testing of the contact lens sensor
on murine patients under normal and diabetic glucose conditions demonstrated a similar
linear response.
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Chapter 5
5 Development of Carbon Dots/Graphene Oxide Glucose
Biosensor
5.1 Introduction
In this chapter, a facile microwave-assisted polyol process was developed to prepare
fluorescent carbon dots. Graphene oxide was synthesized by the typical Hummers’ method.
A Glucose nanobiosensor was developed based on the carbon dots and graphene oxide for
demonstration of carbon dots application in biosensing area. Both carbon dots and
graphene oxide are highly biocompatible. We found that the photoluminescence of carbon
dots could be adjusted by simply varying the ratio of carbon source to ethylene glycol,
which has not yet been reported before. Other methods for preparing different
photoluminescent carbon dots often used oxidative/reductive and/or acid/alkaline
chemicals.

Our

method

is

facile

and

environmental

friendly.

The

tunable

photoluminescence range could extend from 470 nm to 540 nm in this system (excitation
of 400 nm).
Carbon dots are a new member of carbon nanomaterials, the other carbon nanomaterials
include graphene nanomaterials, carbon nanotube, bucky ball etc. [1] Their attracted
properties include good biocompatibility, inertness, facile surface modification and special
photoluminescent properties. [2-3] Various synthetic approaches have been explored for
preparing carbon dots from bottom-up and/or top-down paths. [4-6] Due to carbon dots
favorable fluorescence and low cytotoxicity, they have been broadly applied in areas of
biosensing and bioimaging etc. [7-12] However, the mechanisms of carbon dots special
fluorescence properties are still under debate among investigators. [13-17]
Microwave-assisted synthesis and modification of carbon nanomaterials has been explored
due to carbon materials’ strong interaction with microwave radiation. [18] Microwave
assisted approach represents energy-saving and time-saving strategy for carbon dots
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synthesis. Other common methods for carbon dots like hydrothermal method would often
require several hours or days, high temperature and high pressure procedures. Many
research groups used microwave to fast synthesize carbon dots. [19-23] Different carbon
dots could show excitation-dependent or excitation-independent fluorescence. For
multicolour carbon dots preparation, the reaction parameters like reaction temperature,
reaction additives, doping elements (N, S etc.), pH, reaction time etc. have been widely
investigated. [24-27]
Herein, we developed a facile strategy of synthesizing photoluminescent adjustable carbon
dots at a certain range (470 nm to 540 nm under excitation of 400 nm) by varying
precursors’ concentrations. Zhu et al. [28] has prepared varied precursor concentrations
carbon dots, but the fluorescence change of the carbon dots was within 10 nm range. Our
method could tune carbon dots emission shift up to 70 nm range (sample 1 at 470 nm and
sample 4 at 540 nm under 400 nm excitation). Fluorescent nanomaterials are affected by
various parameters like surface states, solution pH, temperature etc. These parameters are
needed for delicate consideration for nanomaterials in vivo and in vitro applications. In our
carbon dots synthesis, the difference of all samples was the precursor concentration which
could cause different carbon dots surface states. The main reason causing this phenomenon
could be the different ratio of carbon precursors to ethylene glycol. Ethylene glycol is a
reductive agents in the polyol process [29] which acts both as reaction solution and
reductive agents. Comparatively, the solution of ethylene glycol was kept at the same
volume in all the microwave assisted synthesis. The higher carbon precursor concentration
environment are less reductive compared to lower precursor concentrations. As a result,
the higher precursor carbon dots would have a higher oxidative surface state, therefore they
were red-shifted. This speculation was in consistent with other references. [30-31] A higher
oxidative surface state of carbon dots could cause the red-shift phenomenon.
At the same time, even though different samples of carbon dots displayed different colours
under 312 nm UV panel excitation, each sample also behaved the typical excitationdependent fluorescence properties (figure 5.9). Although the mechanism for this
photoluminescence change has not been fully explained. This facile synthesis of carbon
source concentration-induced multicolour carbon dots provided a multicolour platform for
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many applications like electronic display, printing inks, and biosensors. The synthesized
carbon dots were further constructed as glucose nanobiosensor. We developed a
nanostructured glucose biosensor by using fluorescence resonance energy transfer (FRET)
technique. Fluorescence resonance energy transfer (FRET) is an inexpensive and very
sensitive method and has been used in molecule imaging and glucose test. [32-34] FRET
is a distance-dependent energy transfer process from a fluorophore donor (D) to a
fluorophore acceptor (A) in a nonradioactive process. FRET technique has been utilized
for sensing the competitive reactions of glucose and other polysaccharide, such as dextran,
to Concanavalin A (Con A) (a lectin protein that can bind glucose). [35-37]

Figure 5.1 Schematic mechanism of carbon dots/graphene oxide glucose
nanobiosensor.
In this study, we constructed a novel FRET glucose nanobiosensor using carbon dots
(fluorescence donor) and graphene oxide (fluorescence acceptor, quencher). Both carbon
dots and graphene oxide are highly biocompatible. [38-40] Various studies showed the
biocompatibility of carbon dots and graphene oxide. Also the compositions of them are
mostly carbon elements and hydrogen elements. As shown in figure 5.1, Concanavalin A
(Con A) was bioconjugated onto carbon dots surface, the graphene oxide was modified
with chitosan as the fluorescence quenching component. Carbon dots-Con A (CD-CA)
were binding to the graphene oxide-chitosan (GO-CS) and the fluorescence was quenched
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by the graphene oxide. The chitosan we used here are small molecule weight chitosan
which are not so sticky. After the glucose was introduced, the CD-CA were released from
the GO-CS and as a result, the carbon dots fluorescence was recovered.

5.2 Experimental
5.2.1

Materials

Citric acid (251275), L-histidine (H8000, ≥99%), dialysis tube (PRUG10020, MWCO 1
kDa), Concanavalin A from Canavalia ensiformis (Jack bean) (C2010), N-(3Dimethylaminopropyl)-N′-ethylcarbodiimide

hydrochloride

(03450),

N-

Hydroxysuccinimide (130672), Chitosan (448877) were purchased from Sigma-Aldrich.
Graphite flake, natural, -325 mesh, 99.8% (metals basis) (CAAA43209-18) was purchased
from VWR. Ethylene glycol was purchased from Caledon laboratories Ltd. All chemicals
were used as received. Graphite flakes (natural, -325 mesh, 99.8%) was purchased from
VWR International. Paraffin oil was purchased from Caledon Laboratory Chemicals.
Sulfuric acid (H2SO4, 95.0 % − 98.0 %), potassium persulfate (K2S2O8), phosphorus
pentoxide (P2O5), Potassium permanganate (KMnO4), hydrogen peroxide (H2O2, 30 wt.
%), hydrochloric acid (37 %), hydrazine solution (35 wt. %), ammonium hydroxide
solution (28.0− 30.0 wt. %) were purchased from Sigma-Aldrich. The water used in
experiments were of 18.2 MΩ resistivity provided by Barnstead Water Purification System.

5.2.2

Preparation of Carbon Dots

A polyol microwave assisted method was adopted in the preparation of carbon dots. [4142] For synthesizing the carbon dots used for constructing the glucose nanobiosensor, a
typical process was as following: in a 20 mL glass vial, 100 mmol ethylene glycol, 0.5
mmol L-histidine and 0.5 mmol citric acid were added into the vial and mixed well. Then
the vial was put in a home microwave oven and heated for 20 minutes. The deep brown
color indicated the formation of carbon dots. The solutions was dialyzed against water and
freeze-dried to obtain carbon dots powder sample. The powder samples were stored in 4
°C. For synthesizing a series of photoluminescent carbon dots, the chemical quantity were
showed in table 5.1. Five samples were prepared.
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Table 5.1 Summary of carbon source and ethylene glycol quantity.
Ethylene
Sample

glycol (EG)
(mmol)

5.2.3

Carbon

Particle

Histidine

Citric acid

source to

size

(mmol)

(mmol)

EG ratio
(%)

(nm)

1

100

0.1

0.1

0.2

25±1.52

2

100

0.3

0.3

0.6

40±2.13

3

100

0.5

0.5

1.

19±1.12

4

100

1

1

2

40±2.12

5

100

3

3

6

25±1.91

Preparation of CD-Con A Conjugates:

1 mg carbon dots were firstly dissolved in 10 mL PBS buffer (0.1 mg/mL). EDC (1 mg)
and sulfo-NHS (3 mg) were added to the carbon dots solution. The mixture was shaken for
1.5 hour at room temperature. Then the mixture was put to dialysis to remove excess small
molecules. Then 2 mg Con A (dissolved in 2 mL PBS) was added and shaken at 4 °C for
2 hours, the solution was dialyzed against water and stored in 4 °C for future usage.

5.2.4

Preparation of Graphite Oxide

The graphite flakes were first preoxidized according to reference. [43] The oxidizing
solution was prepared by adding 10 g of potassium persulfate and 10 g of phosphorus
pentoxide into 30 mL concentrated sulfuric acid. Then 20 g of graphite flakes was added
into the oxidizing solution. The oxidization process was continued under stirring and at 80
°C for a period of 6 hours. The mixture was diluted with water, filtered and washed until
pH became neutral. The preoxidized graphite flakes was dried in air at room temperature.
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The graphite oxide was prepared according to Hummers’ method. [44] The preoxidized
graphite flakes (10 g) were added into 230 mL cold concentrated sulfuric acid in ice-water
bath. Then 30 g KMnO4 was added gradually with stirring and cooling so to keep the
temperature of the mixture below 20 °C. Then the mixture was stirred at 35 °C for 2 hours.
Then the mixture was diluted by 1,500 mL water and the reaction was terminated by adding
25 mL H2O2 (30 wt. %). The mixture color changed into bright yellow. The graphite oxide
was filtered and washed by 2,500 mL diluted HCl (3.7%) to remove metal ions and then
washed by plenty water. The product was dried in air at room temperature. To completely
remove the metals ions and acid, the graphite oxide was suspended in water to prepare a
viscous, brown 2 wt. % dispersion and put to dialysis. Purified graphite oxide suspension
was diluted into a 0.05 wt. % dispersion and used for following experiments.

5.2.5

Preparation of Graphene Oxide Solution

Graphene oxide was obtained by ultrasonication exfoliation of the 0.05 wt. % graphite
oxide dispersion for 30 minutes. The obtained dispersion was centrifuged at 3,000 rpm for
30 minutes to remove unexfoliated graphite oxide.

Figure 5.2 UV-vis spectrum of graphene oxide solution.
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Figure 5.2 showed the UV-vis spectrum of graphene oxide solution, it has an absorbance
peak of 231 nm. This result is consistent with previous reports, [45-46] confirming the
successful preparation of graphene oxide.

5.2.6

Preparation of GO-CS Conjugates:

Graphene oxide solution (0.05 mg/mL) 10 mL was reacted with 2 mg EDC for 1 hour at
room temperature. Then 2 mg chitosan was added and reacted overnight. Final product was
dialyzed against water and stored in 4 °C for future usage.

5.2.7

GO-CS Titration

GO-CS concentrations were varied. Carbon dots 200 µL (0.1 mg/mL) mixed with 200 µL
GO-CS solutions and incubated for 1 hour before fluorescence measurement.

5.2.8

Glucose Nanobiosensing

In a typical sensing process, 100 µL CDs-Con A solution was mixed with 100 µL (5
µg/mL) GO-CS solution. Thereafter, varied concentration glucose (1 µL) were added and
incubated for 1.5 hour before fluorescence measurement. 1 mM−10 mM: Carbon dots-Con
A 100 µL, GO-CS 100 µL, 5 µg/mL; 0.2 mM−1 mM: Carbon dots-Con A 10 µL + 90 µL
water, GO-CS 100 µL, 1 µg/mL; the mixture was put on a shaker for shaking 40 minutes
at 120 RPM before measure their fluorescence. For the rat blood samples sensing, the
aqueous glucose solution was replaced by rat blood samples.

5.2.9

Rat Blood Samples

This part was cooperated with Dr James Melling lab (Kinesiology, UWO). Four male
Sprague-Dawley rats (Charles River Laboratories, St. Constant, QC, Canada) were housed
in a 12-h light/dark cycle room with humidity (50%) and temperature (21.5 °C) kept
constant. Rats were given water and chow ad libitum and made diabetic with streptozotocin
(STZ; Sigma-Aldrich, Oakville, ON, Canada). Intraperitoneal injections of STZ (20 mg/kg)
dissolved in a citrate buffer (0.1 M, pH 4.5) were given over five consecutive days.
Following the confirmation of diabetes (two blood glucose readings greater than 18
mmol/L) subcutaneous insulin pellets were implanted in the abdominal region of rats. A
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blood sample was taken from the saphenous vein and measured blood glucose
concentration by a glucometer (Freestyle Lite Blood Glucose Monitoring System, Abbott
Diabetes Care Inc., Mississauga, Ontario).
Ethics approval was obtained through the University of Western Ontario Research Ethics
Board, in accordance with Canadian Council on Animal Care guidelines.

5.2.10

Characterizations

The fluorescent emission spectrum of carbon dots aqueous solutions were measured by
fluorophotometry (QuantaMster TM 30, PTI). The size and morphology of the carbon dots
were measured by transmission electron microscope (TEM, Philips CM-10 transmission
electron microscope operating at 80 kV). Fourier transform infrared (FTIR, Bruker Vector
22 in the range of 400 cm-1 −4000 cm-1) was used to obtain FTIR spectrum. UV-vis
spectrum were obtained by Agilent Cary 60 UV-Vis.

5.3 Results and Discussion
5.3.1

Photoluminescent Tunable Carbon Dots

Figure 5.3 Photo image of carbon dots under room light and under 312 nm excitation
from UV panel.
Varied carbon dots samples solution were prepared in the concentration of 0.1 mg/mL.
Figure 5.3 showed the carbon dots solution under ambient light and under the UV panel of
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312 nm excitation light. In the ambient environment, slightly yellow colour change were
observed and the colour deepened from sample 1 to sample 5. Under the UV panel
excitation (312 nm), varied colour emission were presented from blue emission to green
emission to light yellow colour.

Figure 5.4 (a) Photoluminescence spectrum of color tunable carbon dots excited by
400 nm and UV-vis absorbance spectrum of graphene oxide solution; (b) Emission
peaks of carbon dots samples versus carbon source/ethylene glycol ratio (%).
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The fluorescence spectrum of the carbon dots (0.1 mg/mL) was recorded as shown in figure
5.4 (a). Excitation of 400 nm was used to obtain the photoluminescence spectra. Sample 1
to sample 5 has emission peaks at 477 nm, 496 nm, 508 nm, 537 nm and 515 nm,
respectively. The emission peak of sample 5 went back to about the same emission peak
position as sample 3. Figure 5.4 (b) showed the relationship of fluorescence emission peaks
and the ratio of carbon source to ethylene glycol (under excitation of 400 nm). A
polynomial fitting was applied with equation below, with R2=0.996.
Y = 468.34 + 47.47X − 6.61X 2

Figure 5.5 UV-vis absorbance spectrum of carbon dots samples.
The UV spectra of various carbon dots solution were measured and shown in figure 5.5.
Typical absorbance curves of carbon dots were obtained similar to other research results.
[47-50] Sample 3 and sample 5 has an obvious absorbance peak in 300 nm to 500 nm range.
Sample 1, sample 2 and sample 4 showed comparatively weak absorbance peak in 300 nm
to 500 nm range.

114

5.3.2

TEM Images of Carbon dots

TEM images of various carbon dots samples were measured (figure 5.6 and figure 5.7), but
there was not a clearly relationship between the carbon dots particle size and their
fluorescence. Although there was reports of nanoparticles size causing fluorescence
changes, however, this was not the situation. Though the mechanism for precursor amount
induced fluorescence change was not yet fully understood. This facile photoluminescent
tunability provided an easy and environmental friendly method for producing certain
colour emission of carbon dots. Due to the carbon composition of carbon dots, they
normally possessed high biocompatibility and were very suitable for applications such as
biosensing, bioimaging.

Figure 5.6 TEM image of sample 3 carbon dots.
The following parts were focused on constructing biocompatible glucose nanobiosensor
based on sample 3 carbon dots. Figure 5.6 showed the TEM image of sample 3. It has an
average particle size of about 19±1.2 nm. Figure 5.7 showed the TEM images of samples
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1, 2, 4 and 5. Respectively, their average particle size were 25±1.52 nm, 40±2.13 nm,
40±2.12 nm, 25±1.91 nm.

Figure 5.7 TEM images of carbon dots sample 1, 2, 4 and 5.
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5.3.3
Fluorescence of Carbon Dots and Carbon Dots-Con A
Bioconjugate
Figure 5.8 showed the excitation-dependent fluorescence of carbon dots samples 1, 2, 4
and 5 (all 0.1 mg/mL). Figure 5.9 showed the carbon dots (sample 3 for the glucose
nanobiosensor in the following text) fluorescence spectra. Typical excitation-dependent
fluorescence was observed. The excitation wavelength changed from 340 nm to 500 nm
with an increment of 20 nm. The strongest emission was located at about 500 nm by the
excitation of 400 nm or 420 nm.

Figure 5.8 Fluorescent spectrum of carbon dots sample of 1, 2, 4 and 5 (all 0.1 mg/mL).
The fluorescence of carbon dots-Con A bioconjugates were measured and shown in figure
5.10. Figure 5.10 showed similar pattern to figure 5.9 of unmodified carbon dots except
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the twisted spectra were present. The spectrum curve twisted changes indicated the carbon
dots fluorescence changed after the Con A bioconjugation. It reflected the Con A has been
bioconjugated to the carbon dots. While the carbon dots-Con A bioconjugate remained the
excitation-dependent fluorescence. The maxima emission peak was at 492 nm at the
excitation of 400 nm.

Figure 5.9 Fluorescence spectrum of sample 3 carbon dots, (a) Measured spectrum
and (b) Normalized fluorescence intensity spectrum.

Figure 5.10 Fluorescence spectrum of bioconjugate Con A-carbon dots (sample 3), (a)
Measured spectrum and (b) Normalized spectrum.
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5.3.4

UV-vis Spectrum

Figure 5.11 UV-Vis absorbance spectrum of carbon dots, Con A and carbon dots-Con
A bioconjugate.
Con A and carbon dots-Con A bioconjugate were measured to confirm the successful
bioconjugation. Figure 5.11 showed the UV-Vis spectra of carbon dots, Con A and Con Acarbon dots bioconjugate. Carbon dots have an absorbance peak at 339 nm, Con A has an
absorbance peak at 280 nm. The bioconjugate of carbon dots-Con A has two peaks and the
two peaks position were slightly shifted from single component peak. The two peaks
position were at 258 nm (shifted from Con A absorbance peak at 280 nm) and 342 nm
(shifted from carbon dots peak at 339 nm). The bioconjugate has two shifted peaks
compared to their single components. This indicated the successful bioconjugation of Con
A to carbon dots. [51-52]

5.3.5

FTIR Spectrum

Figure 5.12 showed the FTIR spectrum of graphene oxide, graphene oxide-chitosan
conjugate and chitosan. The FTIR spectra indicated successful conjugation of chitosan onto
graphene oxide. The peaks of graphene oxide-chitosan conjugate in the 2981 cm-1 and 2884
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cm-1 indicated the −CH2− groups from chitosan. The graphene oxide peak at 1714 cm-1
disappeared in the GO-CS conjugate showed the EDC conjugation of chitosan to the
carboxylic groups on graphene oxide. The amine group peaks of 1621 cm-1 and 1542 cm-1
of chitosan shifted to 1631 cm-1 and 1567 cm-1 in the GO-CS chitosan also indicated the
bond status changed after conjugation. [53]

Figure 5.12 FTIR spectrum of (a) graphene oxide, (b) graphene oxide-chitosan and
(c) chitosan.

5.3.6

GO-CS Titration of Con A-Carbon Dots

Varied GO-CS concentration solution were mixed and incubated with certain carbon dotsCon A bioconjugate solutions. The fluorescence results were measured as shown in figure
5.13. The quenching effects of GO-CS were clearly presented and a linear quenching
effects was observed. As the GO-CS concentration increased from 0 µg/mL to 10 µg/mL,
the fluorescence of carbon dots were heavily quenched. The curve data were collected from
the intensity at 492 nm.
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Figure 5.13 Fluorescence spectra of GO-CS titration of Con A-carbon dots.

5.3.7

Glucose Nanobiosensing

The glucose biosensing of two range of glucose levels were performed as data shown in
figure 5.14, one glucose range was in the blood glucose level of 1 mM to 10 mM. Another
glucose range was in the tear glucose range of 0.2 mM to 1 mM. Both results suggested
good linear data. Except the lower glucose level biosensing showed less linearity. The
reason may be due to the higher signal to noise ratio. In the 1 mM to 10 mM range, a higher
concentration of graphene oxide-chitosan and carbon dots-Con A were used. In the lower
glucose concentration of 0.2 mM to 1.0 mM, a lower concentration of carbon dots
nanobiosensor were used in order to enlarge the signal-to-noise ratio.
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Figure 5.14 Glucose biosensing of two ranges of glucose level. (a) and (b) shows the
sensing results of glucose level in 1 mM to 10 mM; (c) and (d) shows the sensing results
of glucose in 0.2 mM to 1 mM.
Various diluted rat blood samples of glucose concentration of 3 mM, 4.5 mM, 6 mM, 7.5
mM, 9 mM and 10.5 mM were prepared by dilution of rat blood and measured by the
carbon dots/graphene oxide nanobiosensor. The result was shown in figure 5.15, a good
linearity was obtained. Compared to aqueous glucose solution (figure 5.14 (a) and (b)), the
blood samples has a lower fluorescent intensity. This might be caused by the other
interferents presented in the blood compositions, like red blood cell, blood platelet etc.
These interferents could cause autofluorescence and attenuate the excitation light and
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carbon dots fluorescence. Nonspecific binding of proteins onto carbon dots may also cause
the decrease of fluorescent signal.

Figure 5.15 Biosensing of diluted rat blood samples with glucose concentrations of 3
mM, 4.5 mM, 6 mM, 7.5 mM, 9 mM and 10.5 mM.

5.4 Conclusion
A facile microwave assisted polyol synthesis of carbon dots method was developed. The
photoluminescence of carbon dots could be adjusted at a certain range (470 nm to 540 nm
under 400 nm excitation) by facile control of carbon source concentrations. Although the
mechanism is not fully revealed, but this fluorescence control approach is facile and
environmental friendly. Furthermore, a glucose nanobiosensor based on the carbon
dots/graphene oxide was constructed for biosensing of glucose. Two glucose range of
blood glucose level of 1 mM to 10 mM and tear glucose level of 0.2 mM to 1 mM were
measured and good sensing results were obtained. We also measured the glucose
concentration of a series of diluted rat blood samples and good linearity were obtained. The
flexibility and broad sensing range of the carbon dots/graphene oxide nanobiosensor could
be promising in glucose sensing.
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Chapter 6
6 Development
of
FeCo/graphene
Nanostructured Glucose Biosensor

Magnetoresistive

6.1 Introduction
In this chapter, a facile polyol process, one-step redox reaction, was used to synthesize
Fe50Co50 magnetic nanocrystals and to fabricate magnetic graphene/Fe50Co50 hybrid
nanosheets (MGFCs). The as-synthesized Fe50Co50 magnetic nanocrystals with diameter
around 400 nm have high saturation magnetization of 203.3 emu/g under 1 Tesla. Different
weight ratios of graphene sheets to FeCo nanocrystals were synthesized and optimized to
construct a nanostructured glucose biosensor using magnetoresistive mechanism.
Magnetoresistive structures are promising materials for applications in magnetic sensors,
spintronic devices and magnetic random access memory (MRAM) devices. Recently,
graphene based carbon magnetoresistive materials have attracted great interest due to
graphene’s excellent physicochemical properties. [1-2] Graphene nanosheets have high
Young’s modulus (~1 TPa), large specific surface area (2630 m2 g-1), high intrinsic
mobility (200 000 cm2 v-1 s-1) and high thermal conductivity (~5000 W m-1 K-1), optical
transmittance (~97.7 %) and good electrical conductivity. These outstanding properties of
graphene make them suitable materials for field effect transistors, sensors, biomedical
applications, transparent conductive films, graphene/crystal composites and memory
devices etc. [3-9]
Specifically, graphene/nanomaterials hybrid nanocomposites are being developed as novel
nanosheets for diverse applications. These graphene/nanocrystals hybrid nanostructures
often display advantageous synergistic properties of graphene and crystals. [10-13]
Magnetic graphene composites were prepared by decorating magnetic crystals like FeCo,
NixCo100-x, CoFe2O4, Fe3O4, FeNi3 etc. onto graphene nanosheets. These magnetic
graphene composites have large surface area and were mostly utilized as nanocatalysts.
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And these catalysts were easily separated and purified from solution by external magnetic
field. [14-19] Besides, the magnetic graphene composites were also investigated for their
magnetoresistance applications.
Other nanomaterials and nanostructures were also studied for their magnetoresistive
properties, like electrodeposited single crystal bismuth thin film, [20] non-magnetic silver
chalcogenides. [21] MgO tunnel barriers. [22] These materials and structures showed large
MR values, while graphene have excellent properties and easy synthesis methods,
functionalization and fabrication. More importantly, graphene materials are recognized as
supreme materials for magnetoresistive devices. Both theory studies [23-24] and
experimental studies [25-26] already revealed the suitability of graphene based structures
for magnetoresistive devices. Although at the very stage, magnetoresistance researches
exploited multilayer magnetic/non-magnetic sandwiched structures, granular-matrix
structures were later found to exert magnetoresistive effects as well. Graphene is a very
suitable non-magnetic material for magnetoresistive matrix. The ferromagnetic granular
particles are decorated onto graphene nanosheets with strategy for novel structures and
functions.
In this chapter, we synthesized magnetic graphene/Fe50Co50 hybrid nanosheets (MGFCs)
by decorating Fe50Co50 crystals onto graphene nanosheets via a facile polyol process. The
crystal structure, morphology, magnetic properties and magnetoresistance of FeCo,
FeCo/graphene nanomaterials were studied. The Fe50Co50 crystals and MGFCs showed
excellent ferromagnetic properties with very high saturation magnetization. For
convenience, FeCo was used for representing Fe50Co50 in the thesis. We prepared a series
of FeCo/graphene nanocomposites by changing the graphene quantity from 30 mg to 120
mg with 10 mg step size. The magnetoresistance of the FeCo/graphene samples were
measured and analyzed. Then we selected a ratio (80 mg graphene/FeCo) of
FeCo/graphene nanocomposites as magnetoresistive sensor chip to construct a
nanostructured glucose biosensor. Fe3O4/silica core/shell nanoparticle was used as the
magnetic label. The sensor is shown in the figure 6.1. The sensor chip surface were
modified with Con A, and the magnetic label surface was modified with phenylboronic
acid. The magnetic label thus binded with glucose and sandwiched onto the chip surface.
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The presence of magnetic label changed the magnetoresistance, which would be the
glucose signal.

Figure 6.1 Schematic of nanostructured magnetoresistive glucose biosensor. (a) Facile
polyol process of production of magnetic graphene/Fe50Co50 hybrid nanosheets. (b)
TEM image graphene nanosheet, scale bar 1000 nm. (c) TEM image of magnetic
graphene (120 mg) /Fe50Co50 hybrid nanosheets, scale bar 1000 nm. (d) Hydraulic
press

for

making

magnetic

graphene/Fe50Co50

hybrid

nanosheets

and

magnetoresistance measurements.

6.2 Experimental
6.2.1

Synthesis of Graphene Nanosheets

The graphene sheets used in this study was synthesized through a modified Hummers’
method according to reference. [27] In the synthesis procedure, 1 g of graphite was mixed
with 50 mL concentrated sulfuric acid, then 3 g of potassium permanganate was added
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slowly into the mixture in ice-water bath to avoid overheating. This mixture was then
stirred at room temperature for 20 minutes followed by 10 minutes of sonication. This
stirring-sonication process was repeated for 12 times and then 200 mL water was added
into the mixture. The solution was ultrasonicated for extra 2 hours and the pH was tuned
to neutral by 1 M sodium hydroxide solution. This dispersion was treated with sonication
for another 1 hour. The reduction of the graphene oxide to graphene sheets was carried out
by adding 50 mL hydrazine hydrate into mixture after the mixture temperature reached 95
°C. The reduction process was lasted for 3 hours at 95 °C and then cooled to room
temperature. The black graphene product was filtered and washed by 1 M hydrochloric
acid and water to neutral pH. The black precipitate was freeze-dried store at room
temperature.

6.2.2

Synthesis of Magnetic Fe50Co50 Crystals

The magnetic Fe50Co50 crystals were synthesized through a modified polyol process
according to reference. [28] In a typical synthesis, 2.5 mmol FeCl2·4H2O and 2.5 mmol
Co(CH3COO)2·4H2O metal salts precursors were mixed with 200 mmol sodium hydroxide
in 100 mL ethylene glycol. The mixture was stirred under nitrogen gas protection and
heated to 130 °C. After 1 hour reaction at 130 °C, the black FeCo nanocrystals were
collected by magnet and washed by pure ethanol. The crystals were dried in vacuum under
room temperature.

6.2.3

Synthesis of FeCo/graphene Magnetic Nanocomposites

The synthesis procedure was same as synthesis of FeCo. In a typical synthesis, varied mass
of graphene powder (30 mg to 120 mg with increment of 10 mg), 2.5 mmol FeCl2·4H2O
and 2.5 mmol Co(CH3COO)2·4H2O metal salts precursors were mixed with 200 mmol
sodium hydroxide in 100 mL ethylene glycol. The mixture was stirred under nitrogen gas
protection and heated to 130 °C. After 1 hour reaction at 130 °C, the black FeCo
nanocrystals were collected by magnet and washed by pure ethanol. The crystals were dried
in vacuum under room temperature. Graphene/FeCo composites were pressed and cut by
hole punch into disk with diameter of 3.175 mm, thickness was about 100 µm. The
3.175 mm 2

modification area (single side) is π (

2

) = 7.92 mm2
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6.2.4

APTES Modification of GMR Sensor Surface

The graphene/FeCo surface was first cleaned by water and dried by nitrogen gas. APTES
solution in DMSO (5%, w/v, 2 µL) was carefully applied to the graphene/FeCo surface
area and kept for 4 hours at room temperature. Then the surface was carefully washed by
water and dried by nitrogen gas. Glutaraldehyde solution (10%, 2 µL) was applied to the
surface for 2 hours then the chip was washed and dried by nitrogen gas.

6.2.5

Con A Modification of GMR Sensor Surface

Con A solution (1 mg/mL) of 2 µL was applied to the surface for 2 hours at 4 °C then the
chip was washed, dried and stored in −20 °C. The wash solution was diluted to 100 µL for
BCA protein assay. The adsorbed Con A was measured as 0.162 µg per film (figure 6.2).
The chip surface was first modified with APTES to form the amine groups (−NH2). Then
the Con A were bioconjugated to the amine groups using glutaraldehyde solution. BCA
protein assay was used to measure the Con A quantity. The adsorbed Con A was measured
as 0.162 µg per film.

Figure 6.2 Standard curve of Con A quantification by UV absorbance and quantity
of Con A adsorbed on each MR film.
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6.2.6

Iron Oxide/Silica Surface Modification

Iron oxide (core 7 nm)/silica (shell 22 nm) (total about 50 nm) doped with FITC was
prepared following reference. [29] GLYMO-APB (GA) was prepared following reference.
[30] Glycidyloxypropyltrimethoxysilane (GLYMO) and 3-aminophenylboronic acid
monohydrate (APB) were reacted to prepare boronic-acid bonded GLYMO. Typically,
APB of 50 mg was dissolved in 20 mL of deionized water. The pH of solution was adjusted
to 9.18 by 1 M aqueous NaOH. The, 40 µL of GLYMO was slowly added into the APB
solution with stirring while the solution was put at an ice-bath. The mixed solution was
heated to 40 °C for reaction of 6 h with stirring. Subsequently the solution was placed into
an ice-bath for 5 min, and 40 µL of GLYMO was added and mixed again. Then the solution
was raised to 60 °C for another 6 h with stirring. The prepared GA solution was stored in
a refrigerator for usage. In a typical modification process, 5 mL GA solution, 20 mg iron
oxide/silica was stirring at 75 °C for 2 hours and followed by centrifuge and wash. Then
another 5 mL GA was added to the product for modification. Final product was washed
and centrifuged.

6.2.7

Preparation of 3, 5-Dinitrosalicylic Acid (DNS) Solution

Figure 6.3 Standard curve of glucose concentration by DNS assay and quantity of
glucose adsorbed on each magnetic nanoparticle.
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The DNS solution [31-32] was prepared by the following step. 3, 5-dinitrosalicylic acid
2.5 g, phenol 0.5 g, sodium sulfite 0.075 g, sodium hydroxide 2.5 g, and potassium sodium
tartrate 50 g were dissolved and mixed well in water and the final volume was 500 mL.
After mixing well, the DNS solution was stored in 4 °C fridge. The colorimetric process
was as following. Standard glucose solution 0.25 mL, DNS solution 0.75 mL, mixed and
put in boiling water for 5 minutes. Then use tap water to cool down the solution to room
temperature. Then add 2 mL water to each sample. And put in dark environment at room
temperature for 20 minutes and then measure their UV-vis absorbance. The absorbance at
550 nm was used to draw the standard curve.

Figure 6.4 Standard curve of glucose concentration by DNS assay and quantity of
glucose adsorbed on each MR film.
Glucose/Nanoparticle ratio was measured by DNS glucose colorimetric assay with range
0.2 mg/mL to 1 mg/mL, interval 0.2 mg/mL. 1 mg magnetic nanoparticle label adsorbed
0.220 mg glucose (figure 6.3); each magnetoresistive chip adsorbed 0.011 mg glucose
using the DNS assay (figure 6.4).
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Figure 6.3 showed the glucose standard curve analyzed by DNS colorimetric assay. After
the glucose colorimetric reaction, the DNS solution was measured by UV-vis and the
absorbance at 550 nm was used to quantify the glucose quantity. The calculation was that
1 mg magnetic nanoparticle label adsorbed 0.220 mg glucose.
Similarly, using DNS glucose assay, the glucose adsorbed on each MR sensor was
calculated to be 0.011 mg glucose per film. The glucose contained in 3 µL glucose solution
of 10 mM was 0.0054 mg, which is smaller than the maxima glucose adsorbed on each
film of 0.011 mg.

6.2.8

MR Measurement

Figure 6.5 Quantification of fluorescent magnetic label by doped dye (FITC)
absorbance at 502 nm.
In a typical MR measure, samples of known concentrations of glucose solutions (3 µL, 0.
2 mM to 10 mM) was applied and stayed for 1 hour. Then the chip was washed and dried
by nitrogen gas. Then, 3 µL magnetic nanoparticle solution (10 mg/mL) was added and
stayed at room temperature for 1 hour. The magnetic label solution was washed and
collected into 600 µL volume (~50 µg/mL) for UV measurement. Standard curve was
measured at range from 20 µg/mL to 100 µg/mL, interval 20 µg/mL (figure 6.5).
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The magnetic label was iron oxide/silica core/shell nanoparticle. The shell was doped with
FITC dye, which has an UV-vis absorbance at 502 nm as shown in figure 6.5 (a). Using
the magnetic label fluorescence standard curve (figure 6.5 (b)), we could measure the
amount of magnetic label adsorbed on each MR sensor chip as shown in figure 6.6.
Using figure 6.5, the amount of magnetic label adsorbed on each MR sensor under different
glucose concentrations could be measured as shown in figure 6.6. Because the MR sensor
was first applied with a glucose solution. Then certain amounts of Con A was occupied by
the glucose molecule. Then the magnetic label (saturated by excessive glucose) was
applied, therefore, if the glucose solution has a higher glucose concentration, more Con A
would be occupied. The less magnetic label could be bound onto the sensor.

Figure 6.6 Adsorbed fluorescent magnetic label on each MR sensor chip under
different glucose concentrations.

6.2.9

Rat Blood Samples Sensing

This part was cooperated with Dr James Melling lab (Kinesiology, UWO). In a typical MR
measure. Samples of known concentrations of diluted blood samples (1 µL, 0. 2 mM to 10
mM) was applied to the sensor for 1 hour. Then the sensors were washed and dried by
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nitrogen gas. Ethics approval was obtained through the University of Western Ontario
Research Ethics Board, in accordance with Canadian Council on Animal Care guidelines.

6.3 Results and Discussion
6.3.1

Magnetic Nanoparticle Label Characterization

Figure 6.7 (a) TEM image of iron oxide nanoparticle and inset of iron oxide/silica
core/shell nanoparticle, scale bar 100 nm; (b) Fluorescence spectra of FITC doped
iron oxide/silica core/shell nanoparticle; (c) FTIR spectrum of GA modified FITCiron oxide/silica nanoparticle;

138

The iron oxide nanoparticles were prepared by thermal decomposition approach. From the
iron oxide nanoparticles TEM image, an average nanoparticle size of 7 nm±0.21 nm was
measured by calculating over 100 nanoparticles. The size distribution was narrow.
Furthermore, the iron oxide was surface coated with a silica layer doped with fluorescein
isothiocyanate (FITC) dye. The dye has an excitation wavelength of 492 nm and an
emission wavelength at 527 nm. The doping dye worked as fluorescence label to quantify
the magnetic label using the fact that FITC has UV absorbance at 502 nm.
The silica shell thickness was average 22 nm±3.42 nm. The silica surface was modified
with phenylboronic acid. The phenylboronic acid recognizes glucose and could bind
glucose through a diol hydrogen bond. The FTIR spectrum of the core/shell nanoparticles
confirmed the successful conjugation of phenylboronic acid on silica surface.

Figure 6.8 (a) Magnetic hysteresis loop of Fe3O4 nanoparticles; (b) Magnetic
hysteresis loop of FITC-iron oxide/silica core/shell nanoparticle.
The magnetic properties of iron oxide core and core/shell nanoparticle were characterized
by the vibrating sample magnetometer (VSM). The iron oxide core was superparamagnetic
with a magnetization of 58 emu/g at 1 T. After coated with a shell of silica the
magnetization of the core/shell nanoparticle dropped down to about 0.5 emu/g at 1 T. The
reason should be the silica coating. But from the hysteresis loop of the core/shell
nanoparticle, the core/shell nanoparticles were still superparamagnetic.

139

6.3.2

Magnetoresistance Chip Characterization

Figure 6.9 (a) TEM image of graphene (scale bar 2000 nm), (b) XRD pattern of
graphite and graphene, (c) TEM image (scale bar 100 nm) of single Fe50Co50 crystal,
inset image is corresponding electron diffraction pattern of Fe50Co50 crystal, and (d)
Energy-dispersive X-ray analysis of Fe50Co50 crystals.
Graphene nanosheets were prepared by the Hummers’ method. The FeCo nanoparticle
were prepared by a polyol process. Then varied graphene nanosheets were added into the
FeCo polyol process to obtain the FeCo/graphene magnetic nanocomposites. The graphene
nanosheets were characterized by TEM and XRD as shown in figure 6.9 (a) (b). From the
characteristic XRD spectrum of graphite, graphene oxide and graphene, and compared
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them with references. [33-35] Successful preparation of graphene nanosheets was
confirmed. The FeCo nanoparticle was characterized by TEM and EDX in figure 6.9 (c)
(d). The electron diffraction of FeCo nanoparticle confirmed the FeCo crystal structure.
The EDX spectra showed the FeCo element. The C and Cu signal came from the carbon
copper grid.

Figure 6.10 Magnetic hysteresis loop of graphene nanosheets.
The graphene nanosheets hysteresis loop was shown in figure 6.10, from the weak signal
of the loop (0.02 emu/g at 1 T), we could neglect the graphene nanosheets magnetization
here.
The FeCo nanoparticle size was calculated from figure 6.11 (a) at about average 500 nm.
From the TEM image, the FeCo nanoparticle were severely connected and aggregated. This
may be caused by the particles ferromagnetic property and ultra-strong magnetization of
FeCo nanoparticle (202 emu/g at 1 T in figure 6.11 (b)). Figure 6.11 (c) showed one of the
samples of graphene (30 mg)/FeCo magnetic nanocomposite. The FeCo nanoparticles size
was about 440 nm, and they were dispersed around the graphene nanosheets. The magnetic
hysteresis loops of 3 magnetic FeCo/graphene nanocomposites were presented in figure
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6.11 (d), respectively samples of graphene (30 mg, 60 mg and 120 mg)/FeCo. They have a
magnetization at 1 T of 97 emu/g, 78 emu/g and 40 emu/g for graphene 30 mg, 60 mg and
120 mg. The insets in figure 6.11 (b) (d) demonstrated the ferromagnetic property of FeCo
nanoparticle and graphene/FeCo nanocomposites.

Figure 6.11 Samples morphology and magnetic properties of Fe50Co50 crystals and
magnetic graphene/Fe50Co50 hybrid nanosheets samples: (a) Fe50Co50 crystal (scale
bar 500 nm), (b) FeCo magnetic hysteresis loop, inset showing the enlarged area near
Field=0, (c) G30FeCo hybrids (graphene 30 mg) (scale bar 2000 nm), (d) G30FeCo,
G60FeCo and G120FeCo magnetic nanocomposites magnetic hysteresis loop, inset
showing the enlarged area near Field=0.
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Table 6.1 summarized the magnetic FeCo/graphene nanocomposites samples.
Table 6.1 Magnetic data of FeCo crystal and graphene/FeCo magnetic
nanocomposites at room temperature.
Samples

Ms (emu/g)

Mr (emu/g)

Mr
⁄M
s

Hc (Oe)

Fe50Co50 crystal

203.3

12.81

0.063

110.9

G30FeCo

97.5

5.37

0.055

175.1

G60FeCo

78.0

3.83

0.049

212.1

G120FeCo

39.9

1.59

0.040

174.5

Figure 6.12 Actual FeCo weight ratio data from SEM-EDX spectra of a series of
magnetic graphene/FeCo samples.
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A series of varied quantity of graphene powder to FeCo ratio were prepared and their
magnetoresistance were measured. The graphene quantity were 30 mg up to 120 mg with
10 mg increment. Together we have prepared 10 magnetic graphene/FeCo samples. These
samples were analyzed by SEM-EDX and scanned several spots per sample to get the
actual average FeCo nanoparticles weight percentage in each sample as shown in figure
6.12. The Y axis was the FeCo EDX average measured data, x axis was the added graphene
mass. Figure 6.12 showed that by keeping the FeCo reaction condition unchanged, the
increasing of graphene nanosheets decreased the FeCo nanoparticle weight ratio on the
nanocomposites. A decline trend could be envisioned and fitted using Boltzmann function.

Figure 6.13 Magnetoresistance of a series of varied graphene mass graphene/FeCo
samples.
These samples magnetoresistance were measured as shown in figure 6.13. Y axis was the
magnetoresistance, x axis was the Fe weight ratio. The label in the graph indicated the
added graphene quantity. As the magnetic label was Fe3O4/silica, therefore we made the X
axis into Fe weight ratio. The binding of magnetic label increased the Fe content on the
MR sensor chip. The sample of graphene (80 mg)/FeCo was at a sharp dropping point,
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which showed that a minute increasing of magnetic label could decreased the MR in a
sharp way. Therefore, the graphene (80 mg)/FeCo sample was chosen as the MR sensor
chip.

6.3.3

Glucose Biosensing of Diluted Rats Blood Samples

Figure 6.14 showed the SEM image of FeCo/graphene nanopcomposite sensor chip
surface. The rat blood glucose concentration were measured by marketed glucometer.
Diluted rat blood samples of known glucose concentrations of 2 mM, 4 mM, 6 mM, 8 mM
and 10 mM were measured by the MR sensor chip as showed in figure 6.15. In the sensing
process, diluted blood was applied to the sensor chip surface. Then magnetic label
(saturated by excessive glucose) was applied. Therefore, if the sample has a higher glucose
concentration, the binding of magnetic label would be less. The MR signal was increasing
as the glucose increased.

Figure 6.14 SEM image of nanostructured magnetoresistive glucose biosensor chip
surface.
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Figure 6.15 Nanostructured magnetoresistive biosensor sensing diluted rat blood
glucose concentration.

6.4 Conclusion
In conclusion, we have developed a magnetoresistive nanostructured glucose biosensor.
The MR chip detector was constructed by magnetic graphene/FeCo nanocomposite with
surface bioconjugated with Con A. The magnetic label was iron oxide/silica core/shell
nanoparticle with surface modified with phenylboronic acid. Diluted rat blood samples
with certain glucose concentrations were measured with this MR biosensor with good
results.
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Chapter 7
7 Summary and Recommendations
7.1 Summary and Conclusion

Figure 7.1 Schematic of my work on four nanostructured glucose biosensors.
The overall objective of my PhD work was to develop nanostructured glucose biosensor
(figure 7.1), which utilizes nanomaterials and nanostructures to construct glucose biosensor
with high selectivity and sensitivity. A variety of nanomaterials were prepared and
integrated into several different glucose nanobiosensors. These nanostructured glucose
biosensors were properly functionalized with suitable biomolecules and functional
chemical groups. Rats tear and blood samples were analyzed by the designed
nanobiosensors and good results were achieved. The sensing results demonstrated various
fluorescent/magnetoresistive nanomaterials and nanostructures could be exploited as
glucose biosensors. Three glucose biosensors were based on fluorescence resonance
energy transfer mechanism, respectively ZnO/QD biosensor, upconverting nanomaterials
biosensor and carbon dots-graphene oxide biosensor. The last glucose biosensor was based

150

on magnetoresistance mechanism, this MR sensor was composed of FeCo/graphene
magnetoresistive chip and magnetic label of Fe3O4/silica core/shell nanoparticles. The brief
summary of each glucose biosensor are stated below.
Development of ZnO/QD Patterned Nanostructured Glucose Biosensor
In chapter 3, a nanostructured glucose biosensor was developed to detect glucose in tear
by using fluorescence resonance energy transfer (FRET) quenching mechanism. The
designed FRET pair were CdSe/ZnS quantum dots (donor) and dextran-binding malachite
green (MG-dextran) (quencher). Concanavalin A (Con A) is a lectin protein with specific
affinity to glucose and Con A is bioconjugated onto quantum dots. Con A can also bind
other saccharides like dextran with much lower affinity. The quantum dots-Con A-dextranMG structure was formed. In the presence of glucose, the quenched emission of QDs
through the FRET mechanism was restored by displacing the dextran-MG from Con A. To
have a dual-modulation sensor for convenient and accurate detection, the nanostructured
FRET sensors were assembled onto a patterned ZnO nanorod array deposited on the
synthetic silicone hydrogel. Consequently, the concentration of glucose detected by the
patterned sensor could be converted to fluorescence spectrum with high signal-to-noise
ratio and calibrated image pixel values. The photoluminescence intensity of the patterned
FRET sensor increased linearly with increasing glucose concentration from 0.03 mM to 3
mM, which covered the range of tear glucose levels for both diabetics and healthy people.
Meanwhile, the calibrated values of pixel intensities of the fluorescence images captured
by a handhold fluorescence microscope increased with increasing glucose concentration.
Four male Sprague-Dawley rats with different blood glucose concentrations were utilized
to demonstrate the quick response of the patterned FRET sensor to 2 µL of diluted tear
samples (2 µL original tear mixed with 5 µL PBS solution). The highlights are listed below:
1. This nanostructured biosensor was designed for dual detection of tear glucose.
2. Fluorescence intensity increased linearly with glucose level from 0.03 mM to 3
mM.
3. Image pixel intensity value of the sensor was corresponding to the glucose level.
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4. Animal test indicated that the sensor could measure the glucose concentration in 2
µL diluted rat tear within 30 seconds.
Development of Upconversion NaGdF4: Yb, Er Glucose Biosensor
In chapter 4, a nanostructured glucose biosensor was designed using upconverting
nanomaterials to sense rat tear glucose in vivo. The fluorescence resonance energy transfer
donor was upconverting nanomaterials with surface bioconjugated of Con A. The modified
upconverting nanomaterials were excited by 980 nm near-infrared light and emited visible
light at 541 nm and 655 nm. The acceptor was the malachite green-dextran (MG-dextran),
which could quench the fluorescence emission of 655 nm from upconversion
nanomaterials. These upconverting nanomaterials glucose nanobiosensors were deposited
onto hydrogel surface and applied as contact lens prototype sensor to sense rat tear glucose
in vivo. In the presence of glucose, the quenched emission of upconverting nanomaterials
was restored by displacing the dextran-MG from Con A. The highlights are listed below:
1. The nanostructures acted as an analyte (tear glucose) collector to achieve high
concentration of analyte reacting with the FRET sensor.
2. The upconverting nanostructures exhibited stable fluorescence signals.
3. Large surface-to-volume ratio of the nanostructures could lead to higher selectivity
for glucose sensing.
4. The fluorescence intensity (I) of the FRET sensor as a function of the glucose
concentration have been investigated in vitro and in vivo.
Development of Carbon Dots/Graphene Oxide Glucose Biosensor
In chapter 5, a facile microwave assisted synthesis method of tunable photoluminescent
carbon dots was developed. Glucose nanobiosensor based on this carbon dots and graphene
oxide was constructed. Both carbon dots and graphene oxide are highly biocompatible. We
found that the photoluminescence of carbon dots could be adjusted (within a certain range)
by simply varying carbon source amount, which has not yet been reported before. Other
methods for preparing different photoluminescent carbon dots often use oxidative and/or
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reductive chemicals. While our method is facile and environmental friendly. The tunable
photoluminescence range could extend from 470 nm to 540 nm in this system. The
highlights are listed below:
1. Facile microwave assisted polyol process for preparation of carbon dots, and the
carbon dots fluorescence was tunable by simply adjusting precursor quantity with
a range from 470 nm to 540 nm.
2. This glucose nanobiosensor composed of biocompatible carbon dots (donor) and
graphene oxide (acceptor or quencher) using fluorescence resonance energy
transfer (FRET) quenching technique.
3. Glucose sensing range was adjustable by applying adequate quantity of donor and
acceptor (quencher). Linearity of glucose level of 1 mM to 10 mM and glucose
level of 0.2 mM to 1 mM was obtained.
4. Diluted rat blood samples were measured by carbon dots/graphene oxide based
nanobiosensor with good linearity.
Development of FeCo/graphene Magnetoresistive Nanostructured Glucose Biosensor
In chapter 6, a facile polyol synthesis process was developed to fabricate Magnetic
Graphene/FeCo hybrid nanosheets (MGFCs). These MGFCs were then pressed into thin
films and applied as nanostructured magnetoresistive chip for glucose biosensor. The
magnetoresistive chip surface was modified with Con A, the magnetic nanoparticle label
was Fe3O4/silica with surface modified with phenylboronic acid. The presence of glucose
would connect the magnetic labels to the magnetoresistive chip surface, thus causing the
magnetoresistance signal change. Diluted rat blood samples were measured by the
magnetoresistive biosensor. The tear samples are collected from Dr James Melling’s lab in
Kinesiology, UWO. And the amounts of tear samples collected are very little. Therefore,
in some measurement, we used diluted blood samples. Although diluted blood samples are
not the same with tear samples, the sensing results are useful for future study when we have
enough tear samples. The highlights are listed below:
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1. Facile polyol preparation of FeCo/graphene nanocomposites, and the composition
was tunable by adjusting the FeCo precursor’s quantity and graphene quantity.
2. The MGFCs chip showed magnetoresistive properties and the magnetoresistance
was tunable by using different ratio Fe, Co and graphene quantity.
3. Diluted rat blood samples were measured by this nanostructured magnetoresistive
glucose biosensor with range of 0 mM to 4 mM.

7.2 Contributions of the Research to the Current State of
Knowledge
Diabetes is a worldwide spread disease among populations. It is a chronic disease
characterized by longtime high glucose level of patients. Many complications often
accompany with diabetes disease, causing great suffering to diabetic patients. [1-5] The
high glucose concentration is present in blood and other body fluid like tear, urine, saliva,
sweat etc. [6-7] Therefore, glucose level in human body fluids is the direct biomarker for
diabetes. Controlling blood glucose concentration is currently prevalent approach to
manage diabetes. Measuring blood glucose is the prevalent method to monitor glucose
level in human body. The widely used marketed glucometer is based on electrochemical
sensing technique. But the glucometer requires a certain amount of blood, which is invasive
and sometimes causing infection risk to people. The implanted electrochemical glucometer
on the other hand may have problems like biocompatibility, biofouling of the sensing
electrode and longevity, calibration etc. [8-9] Tear is a continuous body fluid and a good
target for continuous glucose sensing. Certain relationship of tear glucose and blood
glucose does exist and have been investigated since 1930s. Compared to blood glucose
which is often in the level of 4 mM to 20 mM, tear glucose concentration is in the level of
0.1 mM to 0.5 mM. [10-15] Nanomaterials and nanostructures have novel chemical,
physical and biological properties and nanostructured glucose biosensor could have higher
sensitivity and selectivity, which could be integrated into other devices or chips. Contact
lens based nanostructured glucose biosensor is one promising developing direction. Some
limitations include the whether every person is suitable to wear contact lens and the tear
glucose are affected by every person’s eye status (eye disease etc.). These limitations may
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be solved by setting up personal care systems and applied corresponding managements to
individual situations.
All in all, nanostructured glucose biosensor are promising for better monitoring glucose
level and my PhD work is focused on developing fluorescent and magnetoresistive
nanostructured glucose biosensors. A variety of nanomaterials and nanostructures were
prepared and integrated into several glucose nanobiosensors. Good glucose sensing results
were obtained and rat tear samples and rat blood samples were analyzed by the designed
glucose nanobiosensors.
To have a whole view on the nanomaterials and nanostructures studied in my work, let’s
look at the fluorescent nanomaterials chapters. In chapter 3, we used CdSe/ZnS quantum
dots, the coating layer of ZnS greatly lowered the toxicity of the CdSe quantum dots and
enhance its fluorescence. The coating could seal the Cd element inside. This quantum dots
glucose nanobiosensor used UV light as fluorescent source. The emission could be tuned
by tuning quantum dots size. Single UV excitation could excite different emission quantum
dots, which was promising for multiplex sensing.
Comparatively, in chapter 4, we adopted upconverting nanomaterials which were excited
by near-infrared light of 980 nm and emitted visible light at 541 nm and 655 nm. On the
other hand, the use of 980 nm near-infrared excitation could avoid the auto-fluorescence
effect. Therefore, the upconverting nanomaterials based glucose biosensor was a step
forward to enhance the sensor’s signal-to-noise ratio. Moreover, upconverting
nanomaterials have better biocompatibility than the semiconductor quantum dots.
In chapter 5, we used carbon dots, a new nanocarbon materials discovered in 2006, to
develop the fluorescent glucose nanobiosensor. Carbon dots are commonly synthesized by
carbonization of biomolecules or molecules. The composition has carbon, hydrogen,
oxygen elements, sometimes doped with other elements like sulfur, nitrogen etc. Carbon
dots has good biocompatibility and has no toxic elements compared to quantum dots.
Carbon dots has strong fluorescence and excitation-dependent fluorescence properties.
Some carbon dots are reported to have even upconverting properties. Therefore, carbon
dots are promising for biosensor development.
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Table 7.1 Summary of investigated fluorescent nanomaterials.
Fluorescent
nanomaterial

Pros

Cons

CdSe/ZnS

Stable and strong fluorescence

quantum dots

Multiplex sensing

Toxic elements like Cd
UV excitation tissue autofluorescence

980 nm excitation low
background noise
Upconverting
nanomaterial

Biocompatible

Fluorescence difficult to tune

Stable fluorescence
Highly biocompatible
Facile preparation by various
methods
Carbon dots

Fluorescence strong/stable

Fluorescence mechanisms not

enough for biosensing

fully understood

Excitation-dependent emission,

Reproducibility

(carbon
nanomaterial)

tunable by doping nitrogen etc.
elements
Possible upconverting
fluorescence
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Last chapter was focused on carbon nanomaterials based magnetoresistive nanostructured
glucose biosensor. FeCo/graphene nanocomposites were used as magnetoresistive chip and
iron oxide/silica was used as magnetic label.
Development of ZnO/QD Patterned Nanostructured Glucose Biosensor
Quantum dots have stable and strong fluorescent properties, which favor their usage in
various applications. One application of quantum dots is used as fluorescent sensor
transducer. The quantum dots are prepared and the surface modification protocols have
been developed and accumulated. [16-21] The main stream quantum dots contains toxic
semiconductor elements like Cd element, which limit their biomedical applications and
disposal. And the traditional synthesis method would use high boiling point organic
solutions, which are unfriendly to human and environment. Coating of quantum dots is one
method to make them biocompatible, but coating could affect the photoluminescence
properties. In recent years, more and more research has focused on aqueous synthesis of
quantum dots and non-toxic elements containing quantum dots. [22-24] In the ZnO/QD
nanostructured glucose biosensor, we assembled the quantum dots nanobiosensor onto
ZnO nanorod arrays chip. The chip was then patterned using photolithography to show
contrast between sensing parts and non-sensing parts. The large surface area of ZnO
nanorod arrays could enlarge the fluorescent signal. Thus the sensor has high sensitivity.
The chip was deposited on biocompatible hydrogel, making it promising to integrate into
contact lens glucose biosensor. Rat tear samples were measured with good results.
Development of Upconversion NaGdF4: Yb, Er Glucose Biosensor
Upconversion is an anti-Stokes luminescence phenomenon. The excitation source of
upconverting nanomaterials is near-infrared light (normally 980 nm). [25-28] Therefore,
upconverting nanomaterials are very suitable for biosensing applications. Similarly, the
prepared upconverting nanomaterials are surface modified with biocompatible layers like
inorganic or polymer coatings. In the upconverting nanomaterials glucose biosensor. We
developed a method to prepare upconverting nanomaterials with as-synthesized surface
modified by amine group ( − NH2). Then Con A was bioconjugated to upconverting
nanomaterials surface. The modified upconverting nanomaterials were integrated into
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hydrogel materials and applied to sense rat tear in vivo and rat blood sample in vitro with
good results. This nanostructured glucose biosensor demonstrated a contact lens prototype
model for tear glucose sensing.
Development of Carbon Dots/Graphene Oxide Glucose Biosensor
Carbon dots are novel nanocarbon materials. It has good biocompatibility and intriguing
fluorescence properties. Although the exact mechanisms of their fluorescence properties
are not fully uncovered. Their facile synthesis and strong fluorescence properties has
attracted intense research and applied in glucose biosensors area. [29-32] In the carbon dots
glucose nanobiosensor study, we developed a facile microwave assisted polyol preparation
method for synthesizing carbon dots. We found that the carbon dots fluorescence was
tunable from 470 nm to 540 nm by adjusting precursor’s quantity. The precursors were
histidine and citric acid. The polyol process was adopted with solution of ethylene glycol.
Further, we constructed a glucose nanobiosensor using this carbon dots (fluorescence
donor) and graphene oxide (fluorescence quencher). Both the fluorescence donor and
quencher are highly biocompatible and their quantity are adjustable to accommodate
different sensing environment. Rat blood samples were measured by the carbon dots
nanobiosensor with good results.
Development of FeCo/graphene Magnetoresistive Nanostructured Glucose Biosensor
Because most biocomponents do not contain magnetic elements, the magnetic sensing has
zero background noise and high sensitivity. Magnetoresistive biosensors have been
developed and used in sensing other biomolecules, proteins, cells etc. [33-37] In this
magnetoresistive glucose biosensor, we endeavored to develop a magnetoresistive glucose
biosensor. FeCo/graphene nanocomposites were prepared by a polyol process. The
composition of Fe, Co and graphene are tunable by adjusting the precursor ratio. We used
Fe50Co50 nanoparticle formula and change the graphene quantity to study the
magnetoresistance. Then we found a sharp dipping position (graphene (80 mg)/FeCo) of
the magnetoresistance versus graphene quantity curve. We then used the graphene/FeCo
nanocomposites at that dipping point to develop magnetoresistive chip sensor. The
magnetic label of iron oxide/silica core/shell nanoparticles were prepared by thermal
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decomposition and then surface coating with dye-doped silica. Con A was modified onto
chip surface, while the magnetic label were surface modified with phenylboronic groups.
Rat blood samples were measured by this magnetoresistive biosensor with good results.

7.3 Future Studies
My PhD work focused on synthesizing and fabricating different nanomaterials and
nanostructures for glucose biosensor application. Therefore, I would be discussing the
nanomaterials and nanostructures synthesis, surface modification, fabrication and
chemicophysical properties in the following paragraphs. These aspects would greatly affect
biosensors’ biocompatibility, selectivity, sensitivity.
Development of ZnO/QD Patterned Nanostructured Glucose Biosensor
First the toxicity of quantum dots is a general concern for its practical application. However
this problem is intrinsic for Cd quantum dots. A layer of ZnS coating was applied to the
CdSe quantum dots to improve the biocompatibility. A reliable surface modification could
sufficiently lower the quantum dots’ toxicity while retaining the fluorescence. [38-40]
Second the assembling of quantum dots nanobiosensor onto ZnO nanorod could be difficult
to control. Therefore the reproducibility is a concern. The current conjugation method was
using glutaraldehyde. Better conjugation method is required to be able to control the
conjugation process. Third the sensor longevity needs to be considered as well.
Development of Upconversion NaGdF4: Yb, Er Glucose Biosensor
The upconversion nanomaterials used was the NaGdF4, Yb, Er. First the synthesis method
was polyol process at 200 °C at round bottom flask. At this condition, the crystal structures
of the upconverting nanoparticle was difficult to control. XRD results indicated mixed
hexagonal and cubic crystal structures both present in the nanoparticles. The crystal
structure affected greatly the upconverting fluorescence. Hexagonal structure shows
superior fluorescence intensity compared to the cubic. [41-43] So other methods of high
reaction temperatures or using autoclave could better control the crystal structures. Second
consideration was the controlled deposition of upconverting nanomaterials on hydrogel and
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immobilization approach. We used drop casting method and then covered the sensors with
polyethylene glycol. This might need further improvements.
Development of Carbon Dots/Graphene Oxide Glucose Biosensor
This glucose nanobiosensor used carbon nanomaterials, carbon dots (fluorescence donor)
and graphene oxide (fluorescence quencher). Firstly, the graphene oxide reproducibility
was a concern. Graphene oxide is a mixture of different size nanosheets. [44-47] Different
batches of graphene oxide might need calibration to obtain signal reproducibility.
Secondly, the excitation light was 400 nm, which could cause tissue auto-fluorescence
problem. Some research reported the upconverting fluorescence from carbon dots, which
could be excited by 980 nm. [48-50] Therefore, developing upconverting carbon dots or
graphene quantum dots would be advantageous for carbon dots application in biosensors.
Development of FeCo/graphene Magnetoresistive Nanostructured Glucose Biosensor
This study involved also carbon nanomaterials. Graphene nanosheets were decorated with
FeCo nanoparticles through polyol process and iron oxide/silica core/shell magnetic
nanoparticles were used as magnetic label. Firstly, different size of graphene nanosheets
would be a concern. Secondly, other ratios of FeCo nanoparticle to graphene are also
needed to be studied. The FeCo nanoparticle used throughout the experiment was Fe50Co50.
Other FeCo ratios like Fe25Co75 or Fe75Co25 etc. could have different magnetoresistive
effects. Thirdly, the chip surface nanostructures would need more controllable fabrication
process.
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